{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:17:16Z","timestamp":1783772236028,"version":"3.55.0"},"publisher-location":"Cham","reference-count":395,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_12","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:16:03Z","timestamp":1783768563000},"page":"325-364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic alterations in Myeloid Malignancies"],"prefix":"10.1007","author":[{"given":"Bruno Ant\u00f3nio","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"issue":"1","key":"12_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10238-025-01783-z","volume":"25","author":"M Abdar Esfahani","year":"2025","unstructured":"Abdar Esfahani M, Servatian N, Al-Athari AJH, Khafaja ESM, Rahmani Seraji H, Soleimani Samarkhazan H (2025) The epigenetic revolution in hematology: from benchside breakthroughs to clinical transformations. Clin Exp Med 25(1):230","journal-title":"Clin Exp Med"},{"issue":"2","key":"12_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","volume":"22","author":"O Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH et al (2012) ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 22(2):180\u2013193","journal-title":"Cancer Cell"},{"issue":"1","key":"12_CR3","first-page":"144","volume":"114","author":"O Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M et al (2009) Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood, The Journal of the American Society of Hematology 114(1):144\u2013147","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"7","key":"12_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/leu.2011.82","volume":"25","author":"O Abdel-Wahab","year":"2011","unstructured":"Abdel-Wahab O, Pardanani A, Rampal R, Lasho TL, Levine RL, Tefferi A (2011) DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia 25(7):1219\u20131220","journal-title":"Leukemia"},{"issue":"7714","key":"12_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson S, Collord G, Ng SW, Weissbrod O, Mendelson Cohen N et al (2018) Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559(7714):400\u2013404","journal-title":"Nature"},{"key":"12_CR6","doi-asserted-by":"crossref","unstructured":"Adams PD, Latif AL, Newcombe A, Robertson N, Terradas M, Stewart H et al (2018) BET inhibitors potentiate activation of p53 and killing of AML by MDM2 inhibitors\u2014a candidate combination therapy.","DOI":"10.1182\/blood-2018-99-115509"},{"issue":"3","key":"12_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41375-024-02511-4","volume":"39","author":"HM Addinsell","year":"2025","unstructured":"Addinsell HM, Cant R, Hull NJ, Wang YH, Somervaille TC, Wiseman DH, Batta K (2025) Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization. Leukemia 39(3):770\u2013774","journal-title":"Leukemia"},{"issue":"4","key":"12_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00667-9","volume":"12","author":"S Adnan Awad","year":"2022","unstructured":"Adnan Awad S, Br\u00fcck O, Shanmuganathan N, Jarvinen T, L\u00e4hteenm\u00e4ki H, Klievink J et al (2022) Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation. Blood Cancer J 12(4):69","journal-title":"Blood Cancer J"},{"issue":"1","key":"12_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0609.2005.00559.x","volume":"76","author":"A Aggerholm","year":"2006","unstructured":"Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P (2006) Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol 76(1):23\u201332","journal-title":"Eur J Haematol"},{"issue":"7","key":"12_CR10","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBDO, Berti E et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748","journal-title":"Leukemia"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"804408","DOI":"10.3389\/fimmu.2021.804408","volume":"12","author":"S Alanazi","year":"2021","unstructured":"Alanazi S, Rabelo Melo F, Pejler G (2021) Tryptase regulates the epigenetic modification of core histones in mast cell leukemia cells. Front Immunol 12:804408","journal-title":"Front Immunol"},{"issue":"1","key":"12_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8091","volume":"6","author":"G Amabile","year":"2015","unstructured":"Amabile G, Di Ruscio A, M\u00fcller F, Welner RS, Yang H, Ebralidze AK et al (2015) Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun 6(1):7091","journal-title":"Nat Commun"},{"issue":"1","key":"12_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09937-w","volume":"10","author":"M Ando","year":"2019","unstructured":"Ando M, Saito Y, Xu G, Bui NQ, Medetgul-Ernar K, Pu M et al (2019) Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers. Nat Commun 10(1):2188","journal-title":"Nat Commun"},{"key":"12_CR15","doi-asserted-by":"crossref","unstructured":"Anil V, Gosal H, Kaur H, Ngassa HC, Elmenawi KA & Mohammed L (2021) Chronic neutrophilic leukemia: A literature review of the rare myeloproliferative pathology. Cureus 13(6).","DOI":"10.7759\/cureus.15433"},{"issue":"13","key":"12_CR16","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00018-019-03084-7","volume":"76","author":"S Asada","year":"2019","unstructured":"Asada S, Fujino T, Goyama S, Kitamura T (2019) The role of ASXL1 in hematopoiesis and myeloid malignancies. Cell Mol Life Sci 76(13):2511\u20132523","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"12_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-018-0142-y","volume":"6","author":"A Aujla","year":"2018","unstructured":"Aujla A, Linder K, Iragavarapu C, Karass M, Liu D (2018) SRSF2 mutations in myelodysplasia\/myeloproliferative neoplasms. Biomark Res 6(1):29","journal-title":"Biomark Res"},{"issue":"3","key":"12_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381\u2013395","journal-title":"Cell Res"},{"issue":"6824","key":"12_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/35065138","volume":"410","author":"AJ Bannister","year":"2001","unstructured":"Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, Kouzarides T (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410(6824):120\u2013124","journal-title":"Nature"},{"key":"12_CR20","first-page":"3794","volume":"130","author":"H Bansal","year":"2017","unstructured":"Bansal H, Kornblau S, Yihua Q, Coombes KR, Panneerdoss S, Karnad A et al (2017) Overexpression of BRD4 is an adverse prognostic factor in acute myeloid leukemia. Blood 130:3794","journal-title":"Blood"},{"issue":"4","key":"12_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/cimb47040227","volume":"47","author":"P Barone","year":"2025","unstructured":"Barone P, Bottaro A, Leanza R, Stagno F, Allegra A (2025) DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications. Curr Issues Mol Biol 47(4):227","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"12_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823\u2013837","journal-title":"Cell"},{"issue":"9464","key":"12_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. The Lancet 365(9464):1054\u20131061","journal-title":"The Lancet"},{"issue":"17","key":"12_CR25","first-page":"2705","volume":"124","author":"R Bejar","year":"2014","unstructured":"Bejar R, Lord A, Stevenson K, Bar-Natan M, P\u00e9rez-Ladaga A, Zaneveld J et al (2014) TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. Blood, the Journal of the American Society of Hematology 124(17):2705\u20132712","journal-title":"Blood, the Journal of the American Society of Hematology"},{"issue":"15","key":"12_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1182\/blood.2023023727","volume":"144","author":"E Bernard","year":"2024","unstructured":"Bernard E, Hasserjian RP, Greenberg PL, Arango Ossa JE, Creignou M, Tuechler H et al (2024) Molecular taxonomy of myelodysplastic syndromes and its clinical implications. Blood 144(15):1617\u20131632","journal-title":"Blood"},{"issue":"11","key":"12_CR27","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nsmb1337","volume":"14","author":"SR Bhaumik","year":"2007","unstructured":"Bhaumik SR, Smith E, Shilatifard A (2007) Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 14(11):1008\u20131016","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"12_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29142-6","volume":"13","author":"M Binder","year":"2022","unstructured":"Binder M, Carr RM, Lasho TL, Finke CM, Mangaonkar AA, Pin CL et al (2022) Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia. Nat Commun 13(1):1434","journal-title":"Nat Commun"},{"issue":"4","key":"12_CR29","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1096\/fj.201801035R","volume":"33","author":"M Biswas","year":"2019","unstructured":"Biswas M, Chatterjee SS, Boila LD, Chakraborty S, Banerjee D, Sengupta A (2019) MBD3\/NuRD loss participates with KDM6A program to promote DOCK5\/8 expression and Rac GTPase activation in human acute myeloid leukemia. FASEB J 33(4):5268\u20135286","journal-title":"FASEB J"},{"issue":"8","key":"12_CR30","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/1878-0261.12744","volume":"14","author":"P Blecua","year":"2020","unstructured":"Blecua P, Martinez-Verbo L, Esteller M (2020) The DNA methylation landscape of hematological malignancies: an update. Mol Oncol 14(8):1616\u20131639","journal-title":"Mol Oncol"},{"issue":"5","key":"12_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00412-009-0221-9","volume":"118","author":"O Bogdanovi\u0107","year":"2009","unstructured":"Bogdanovi\u0107 O, Veenstra GJC (2009) DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 118(5):549\u2013565","journal-title":"Chromosoma"},{"issue":"9","key":"12_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4161\/epi.21615","volume":"7","author":"YS Bogliotti","year":"2012","unstructured":"Bogliotti YS, Ross PJ (2012) Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development. Epigenetics 7(9):976\u2013981","journal-title":"Epigenetics"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.exphem.2017.10.002","volume":"58","author":"LD Boila","year":"2018","unstructured":"Boila LD, Chatterjee SS, Banerjee D, Sengupta A (2018) KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia. Exp Hematol 58:44\u201351","journal-title":"Exp Hematol"},{"issue":"1","key":"12_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36193-w","volume":"14","author":"M Boy","year":"2023","unstructured":"Boy M, Bisio V, Zhao LP, Guidez F, Schell B, Lereclus E et al (2023) Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation. Nat Commun 14(1):588","journal-title":"Nat Commun"},{"issue":"10","key":"12_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","volume":"19","author":"CA Bradbury","year":"2005","unstructured":"Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT et al (2005) Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19(10):1751\u20131759","journal-title":"Leukemia"},{"issue":"4","key":"12_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/antiox10040572","volume":"10","author":"PC Bradshaw","year":"2021","unstructured":"Bradshaw PC (2021) Acetyl-CoA metabolism and histone acetylation in the regulation of aging and lifespan. Antioxidants 10(4):572","journal-title":"Antioxidants"},{"issue":"1","key":"12_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1182\/hematology.2023000448","volume":"2023","author":"M Breccia","year":"2023","unstructured":"Breccia M (2023) Atypical CML: diagnosis and treatment. Hematology 2023(1):476\u2013482","journal-title":"Hematology"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fcell.2019.00136","volume":"7","author":"J Bugler","year":"2019","unstructured":"Bugler J, Kinstrie R, Scott MT, Vetrie D (2019) Epigenetic reprogramming and emerging epigenetic therapies in CML. Front Cell Dev Biol 7:136","journal-title":"Front Cell Dev Biol"},{"issue":"45","key":"12_CR39","doi-asserted-by":"publisher","first-page":"42462","DOI":"10.1074\/jbc.C100466200","volume":"276","author":"S Burma","year":"2001","unstructured":"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ (2001) ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 276(45):42462\u201342467","journal-title":"J Biol Chem"},{"issue":"1","key":"12_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5045\/br.2021.2021152","volume":"57","author":"JM Byun","year":"2022","unstructured":"Byun JM, Yoo SJ, Kim HJ, Ahn JS, Koh Y, Jang JH, Yoon SS (2022) IDH1\/2 mutations in acute myeloid leukemia. Blood Res 57(1):13\u201319","journal-title":"Blood Res"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fonc.2012.00026","volume":"2","author":"J Cao","year":"2012","unstructured":"Cao J, Yan Q (2012) Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol 2:26","journal-title":"Front Oncol"},{"issue":"1","key":"12_CR42","first-page":"10","volume":"34","author":"MC Carter","year":"2013","unstructured":"Carter MC, Metcalfe DD, Komarow HD (2013) Mastocytosis. Immunol Allergy Clin North Am 34(1):10\u20131016","journal-title":"Immunol Allergy Clin North Am"},{"issue":"11","key":"12_CR43","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/ng.3420","volume":"47","author":"A Caye","year":"2015","unstructured":"Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O et al (2015) Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nature Genet 47(11):1334\u20131340","journal-title":"Nature Genet"},{"issue":"17","key":"12_CR44","first-page":"2635","volume":"124","author":"F Cervantes","year":"2014","unstructured":"Cervantes F (2014) How I treat myelofibrosis. Blood, The Journal of the American Society of Hematology 124(17):2635\u20132642","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"21","key":"12_CR45","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.18632\/oncotarget.4213","volume":"6","author":"A Chatterjee","year":"2015","unstructured":"Chatterjee A, Ghosh J, Kapur R (2015) Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder. Oncotarget 6(21):18250","journal-title":"Oncotarget"},{"issue":"26","key":"12_CR46","doi-asserted-by":"publisher","first-page":"16916","DOI":"10.1073\/pnas.262443999","volume":"99","author":"F Chedin","year":"2002","unstructured":"Chedin F, Lieber MR, Hsieh CL (2002) The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proceedings of the National Academy of Sciences 99(26):16916\u201316921","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7433","key":"12_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature11742","volume":"493","author":"Q Chen","year":"2013","unstructured":"Chen Q, Chen Y, Bian C, Fujiki R, Yu X (2013) TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493(7433):561\u2013564","journal-title":"Nature"},{"issue":"1","key":"12_CR48","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1038\/bcj.2013.74","volume":"4","author":"TC Chen","year":"2014","unstructured":"Chen TC, Hou HA, Chou WC, Tang JL, Kuo YY, Chen CY et al (2014) Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood Cancer J 4(1):e177\u2013e177","journal-title":"Blood Cancer J"},{"issue":"1","key":"12_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","volume":"4","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, He C, Wang M, Ma X, Mo F, Yang S et al (2019) Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther 4(1):62","journal-title":"Signal Transduct Target Ther"},{"key":"12_CR50","doi-asserted-by":"crossref","unstructured":"Cheung KL, Kim C & Zhou MM (2021) The functions of BET proteins in gene transcription of biology and diseases. Front Mol Biosci 8: 728777.","DOI":"10.3389\/fmolb.2021.728777"},{"issue":"4","key":"12_CR51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0092-8674(03)00355-6","volume":"113","author":"WL Cheung","year":"2003","unstructured":"Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA et al (2003) Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 113(4):507\u2013517","journal-title":"Cell"},{"issue":"7","key":"12_CR52","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cub.2005.02.049","volume":"15","author":"WL Cheung","year":"2005","unstructured":"Cheung WL, Turner FB, Krishnamoorthy T, Wolner B, Ahn SH, Foley M et al (2005) Phosphorylation of histone H4 serine 1 during DNA damage requires casein kinase II in S. cerevisiae. Curr Biol 15(7):656\u2013660","journal-title":"Curr Biol"},{"issue":"12","key":"12_CR53","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.3390\/cancers13123078","volume":"13","author":"YC Chia","year":"2021","unstructured":"Chia YC, Islam MA, Hider P, Woon PY, Johan MF, Hassan R, Ramli M (2021) The prevalence of TET2 gene mutations in patients with BCR-ABL-negative myeloproliferative neoplasms (MPN): a systematic review and meta-analysis. Cancers 13(12):3078","journal-title":"Cancers"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3410\/B1-98","volume":"1","author":"CM Chiang","year":"2009","unstructured":"Chiang CM (2009) Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000 Biol Rep 1:98","journal-title":"F1000 Biol Rep"},{"issue":"4","key":"12_CR55","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/bjh.18273","volume":"198","author":"EJ Choi","year":"2022","unstructured":"Choi EJ, Cho YU, Hur EH, Park HS, Choi Y, Lee JH et al (2022) Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome. Br J Haematol 198(4):703\u2013712","journal-title":"Br J Haematol"},{"issue":"1","key":"12_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOH.0000000000000688","volume":"29","author":"I Cobo","year":"2022","unstructured":"Cobo I, Tanaka T, Glass CK, Yeang C (2022) Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease. Curr Opin Hematol 29(1):1\u20137","journal-title":"Curr Opin Hematol"},{"key":"12_CR57","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood-2023-186967","volume":"142","author":"SG Cockey","year":"2023","unstructured":"Cockey SG, Zhang H, Hussaini MO, Zhang L, Moscinski LC, Yang E, Song J (2023) A Large Cohort study of 412 patients with SRSF2\/TET2 co-mutated myeloid neoplasms: The molecular landscape and clinical outcomes. Blood 142:1882","journal-title":"Blood"},{"issue":"5","key":"12_CR58","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/nar\/gky1290","volume":"47","author":"KE Connelly","year":"2019","unstructured":"Connelly KE, Weaver TM, Alpsoy A, Gu BX, Musselman CA, Dykhuizen EC (2019) Engagement of DNA and H3K27me3 by the CBX8 chromodomain drives chromatin association. Nucleic Acids Res 47(5):2289\u20132305","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"12_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/cancers10030059","volume":"10","author":"D Corujo","year":"2018","unstructured":"Corujo D, Buschbeck M (2018) Post-translational modifications of H2A histone variants and their role in cancer. Cancers 10(3):59","journal-title":"Cancers"},{"issue":"18","key":"12_CR60","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.3390\/ijms21186862","volume":"21","author":"E Cris\u00e0","year":"2020","unstructured":"Cris\u00e0 E, Nicolosi M, Ferri V, Favini C, Gaidano G, Patriarca A (2020) Atypical chronic myeloid leukemia: where are we now? Int J Mol Sci 21(18):6862","journal-title":"Int J Mol Sci"},{"key":"12_CR61","doi-asserted-by":"crossref","unstructured":"Csizmar CM, Natu AA, Gurney M, Kanagal-Shamanna R, Loghavi S, Bazinet A et al (2024) Prognostic Impact of the Number of TET2 Mutations in Myelodysplastic and Myeloproliferative Chronic Myelomonocytic Leukemia (CMML).","DOI":"10.1182\/blood-2024-209193"},{"issue":"1","key":"12_CR62","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S et al (2024) Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Ther 9(1):332","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"12_CR63","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.celrep.2012.08.016","volume":"2","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Foster SD, Bannister AJ, Robson SC, Hannah R, Wang X et al (2012) Three distinct patterns of histone H3Y41 phosphorylation mark active genes. Cell Rep 2(3):470\u2013477","journal-title":"Cell Rep"},{"issue":"7370","key":"12_CR64","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10509","volume":"478","author":"MA Dawson","year":"2011","unstructured":"Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Kouzarides T (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478(7370):529\u2013533","journal-title":"Nature"},{"issue":"10","key":"12_CR65","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes & development 25(10):1010\u20131022","journal-title":"Genes & development"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2014.00155","volume":"5","author":"V Dehennaut","year":"2014","unstructured":"Dehennaut V, Leprince D, Lefebvre T (2014) O-GlcNAcylation, an epigenetic mark. Focus on the histone code, TET family proteins, and polycomb group proteins. Front Endocrinol 5:155","journal-title":"Front Endocrinol"},{"issue":"22","key":"12_CR67","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Valle VD, James C, Trannoy S, Mass\u00e9 A et al (2009) Mutation in TET2 in myeloid cancers. N Engl J Med 360(22):2289\u20132301","journal-title":"N Engl J Med"},{"issue":"2","key":"12_CR68","first-page":"27","volume":"77","author":"DH Desmond","year":"2018","unstructured":"Desmond DH, Carmichael MG (2018) Systemic mastocytosis: the difficult patient with a rare disease. Case presentation and brief review. Hawai\u2019i Journal of Medicine & Public Health 77(2):27","journal-title":"Hawai\u2019i Journal of Medicine & Public Health"},{"issue":"1-2","key":"12_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mrfmmm.2008.07.007","volume":"647","author":"A Dhasarathy","year":"2008","unstructured":"Dhasarathy A, Wade PA (2008) The MBD protein family\u2014reading an epigenetic mark? Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis 647(1-2):39\u201343","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"issue":"4","key":"12_CR70","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/leu.2015.211","volume":"30","author":"CD DiNardo","year":"2016","unstructured":"DiNardo CD, Jabbour E, Ravandi F, Takahashi K, Daver N, Routbort M et al (2016) IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression. Leukemia 30(4):980\u2013984","journal-title":"Leukemia"},{"issue":"6","key":"12_CR71","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1074\/mcp.M500327-MCP200","volume":"5","author":"YC Du","year":"2006","unstructured":"Du YC, Gu S, Zhou J, Wang T, Cai H, MacInnes MA et al (2006) The dynamic alterations of H2AX complex during DNA repair detected by a proteomic approach reveal the critical roles of Ca2+\/calmodulin in the ionizing radiation-induced cell cycle arrest. Mol Cell Proteomics 5(6):1033\u20131044","journal-title":"Mol Cell Proteomics"},{"key":"12_CR72","doi-asserted-by":"publisher","first-page":"651317","DOI":"10.3389\/fcell.2021.651317","volume":"9","author":"X Du","year":"2021","unstructured":"Du X, Hu H (2021) The roles of 2-hydroxyglutarate. Front Cell Dev Biol 9:651317","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"12_CR73","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1074\/jbc.M113.540732","volume":"289","author":"MR Duan","year":"2014","unstructured":"Duan MR, Smerdon MJ (2014) Histone H3 lysine 14 (H3K14) acetylation facilitates DNA repair in a positioned nucleosome by stabilizing the binding of the chromatin Remodeler RSC (Remodels Structure of Chromatin). J Biol Chem 289(12):8353\u20138363","journal-title":"J Biol Chem"},{"issue":"1","key":"12_CR74","first-page":"61","volume":"136","author":"AJ Dunbar","year":"2020","unstructured":"Dunbar AJ, Rampal RK, Levine R (2020) Leukemia secondary to myeloproliferative neoplasms. Blood, The Journal of the American Society of Hematology 136(1):61\u201370","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"2","key":"12_CR75","doi-asserted-by":"publisher","first-page":"e1111","DOI":"10.1002\/cnr2.1111","volume":"1","author":"MH Elias","year":"2018","unstructured":"Elias MH, Azlan H, Sulong S, Baba AA, Ankathil R (2018) Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients. Cancer Reports 1(2):e1111","journal-title":"Cancer Reports"},{"issue":"10","key":"12_CR76","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/ajh.25214","volume":"93","author":"EH Estey","year":"2018","unstructured":"Estey EH (2018) Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol 93(10):1267\u20131291","journal-title":"Am J Hematol"},{"issue":"5","key":"12_CR77","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","volume":"62","author":"JP Etchegaray","year":"2016","unstructured":"Etchegaray JP, Mostoslavsky R (2016) Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes. Mol Cell 62(5):695\u2013711","journal-title":"Mol Cell"},{"key":"12_CR78","doi-asserted-by":"crossref","unstructured":"Fabiani E, Leone G, Giachelia M, D\u2019alo\u2019 F, Greco M, Criscuolo M et al (2010) Analysis of genome-wide methylation and gene expression induced by 5-aza-2\u2032-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. Leukemia & lymphoma 51(12):2275-2284.","DOI":"10.3109\/10428194.2010.528093"},{"issue":"3","key":"12_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tem.2018.12.002","volume":"30","author":"Y Fang","year":"2019","unstructured":"Fang Y, Tang S, Li X (2019) Sirtuins in metabolic and epigenetic regulation of stem cells. Trends in Endocrinology & Metabolism 30(3):177\u2013188","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"4","key":"12_CR80","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.12.009","volume":"28","author":"Y Fang","year":"2021","unstructured":"Fang Y, Xu X, Ding J, Yang L, Doan MT, Karmaus PW et al (2021) Histone crotonylation promotes mesoendodermal commitment of human embryonic stem cells. Cell Stem Cell 28(4):748\u2013763","journal-title":"Cell Stem Cell"},{"key":"12_CR81","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mrrev.2016.03.005","volume":"768","author":"Z Farooq","year":"2016","unstructured":"Farooq Z, Banday S, Pandita TK, Altaf M (2016) The many faces of histone H3K79 methylation. Mutation Research\/Reviews in Mutation Research 768:46\u201352","journal-title":"Mutation Research\/Reviews in Mutation Research"},{"issue":"18","key":"12_CR82","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.3390\/ijms251810214","volume":"25","author":"F Fei","year":"2024","unstructured":"Fei F, Jariwala A, Pullarkat S, Loo E, Liu Y, Tizro P et al (2024) Genomic landscape of myelodysplastic\/myeloproliferative neoplasms: a multi-central study. Int J Mol Sci 25(18):10214","journal-title":"Int J Mol Sci"},{"issue":"9865","key":"12_CR83","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0140-6736(12)61727-9","volume":"381","author":"F Ferrara","year":"2013","unstructured":"Ferrara F, Schiffer CA (2013) Acute myeloid leukaemia in adults. The Lancet 381(9865):484\u2013495","journal-title":"The Lancet"},{"key":"12_CR84","doi-asserted-by":"publisher","first-page":"225","DOI":"10.7554\/eLife.12626","volume":"5","author":"O Fiehn","year":"2016","unstructured":"Fiehn O, Showalter MR, Schaner-Tooley CE, Reproducibility Project: Cancer Biology (2016) Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. eLife 5:225\u2013234","journal-title":"eLife"},{"issue":"6","key":"12_CR86","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A et al (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18(6):553\u2013567","journal-title":"Cancer Cell"},{"issue":"5","key":"12_CR87","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/cancers14051335","volume":"14","author":"C Fi\u00f1ana","year":"2022","unstructured":"Fi\u00f1ana C, G\u00f3mez-Molina N, Alonso-Moreno S, Belver L (2021) Genomic and epigenomic landscape of juvenile myelomonocytic leukemia. Cancers 14(5):1335","journal-title":"Cancers"},{"issue":"11","key":"12_CR88","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/leu.2014.119","volume":"28","author":"W Fiskus","year":"2014","unstructured":"Fiskus W, Sharma S, Shah B, Portier BP, Devaraj SG, Liu K et al (2014) Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells. Leukemia 28(11):2155\u20132164","journal-title":"Leukemia"},{"issue":"6","key":"12_CR89","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2022.05.006","volume":"29","author":"MA Florez","year":"2022","unstructured":"Florez MA, Tran BT, Wathan TK, DeGregori J, Pietras EM, King KY (2022) Clonal hematopoiesis: Mutation-specific adaptation to environmental change. Cell Stem Cell 29(6):882\u2013904","journal-title":"Cell Stem Cell"},{"issue":"11","key":"12_CR90","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3324\/haematol.11280","volume":"92","author":"C Flotho","year":"2007","unstructured":"Flotho C, Kratz CP, Niemeyer CM (2007) How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia. Haematologica 92(11):1441\u20131446","journal-title":"Haematologica"},{"issue":"12","key":"12_CR91","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3324\/haematol.2013.092007","volume":"99","author":"CY Fong","year":"2014","unstructured":"Fong CY, Morison J, Dawson MA (2014) Epigenetics in the hematologic malignancies. Haematologica 99(12):1772","journal-title":"Haematologica"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"756348","DOI":"10.3389\/fonc.2021.756348","volume":"11","author":"D Fontana","year":"2021","unstructured":"Fontana D, Gambacorti-Passerini C, Piazza R (2021) Molecular pathogenesis of BCR-ABL-negative atypical chronic myeloid leukemia. Front Oncol 11:756348","journal-title":"Front Oncol"},{"issue":"11","key":"12_CR93","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1021\/acs.chemrev.5b00003","volume":"115","author":"J Fuhrmann","year":"2015","unstructured":"Fuhrmann J, Clancy KW, Thompson PR (2015) Chemical biology of protein arginine modifications in epigenetic regulation. Chem Rev 115(11):5413\u20135461","journal-title":"Chem Rev"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.exphem.2020.01.002","volume":"83","author":"T Fujino","year":"2020","unstructured":"Fujino T, Kitamura T (2020) ASXL1 mutation in clonal hematopoiesis. Exp Hematol 83:74\u201384","journal-title":"Exp Hematol"},{"key":"12_CR95","doi-asserted-by":"crossref","unstructured":"Fuster JJ, Zuriaga MA, Zorita V, MacLauchlan S, Polackal MN, Viana-Huete V et al (2020) TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity. Cell Rep 33(4).","DOI":"10.1016\/j.celrep.2020.108326"},{"issue":"3","key":"12_CR96","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.cr.7310149","volume":"17","author":"P Gallinari","year":"2007","unstructured":"Gallinari P, Marco SD, Jones P, Pallaoro M, Steink\u00fchler C (2007) HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res 17(3):195\u2013211","journal-title":"Cell Res"},{"issue":"1","key":"12_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01771-2","volume":"16","author":"Q Gao","year":"2024","unstructured":"Gao Q, Shen K, Xiao M (2024) TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights. Clin Epigenetics 16(1):155","journal-title":"Clin Epigenetics"},{"issue":"2","key":"12_CR98","doi-asserted-by":"publisher","first-page":"e55481","DOI":"10.1371\/journal.pone.0055481","volume":"8","author":"XN Gao","year":"2013","unstructured":"Gao XN, Lin J, Ning QY, Gao L, Yao YS, Zhou JH et al (2013) A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. PLoS One 8(2):e55481","journal-title":"PLoS One"},{"issue":"2","key":"12_CR99","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0022-2836(87)90689-9","volume":"196","author":"M Gardiner-Garden","year":"1987","unstructured":"Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196(2):261\u2013282","journal-title":"J Mol Biol"},{"issue":"35","key":"12_CR100","doi-asserted-by":"publisher","first-page":"14456","DOI":"10.1074\/jbc.M117.802074","volume":"292","author":"LA Gates","year":"2017","unstructured":"Gates LA, Shi J, Rohira AD, Feng Q, Zhu B, Bedford MT et al (2017) Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation. J Biol Chem 292(35):14456\u201314472","journal-title":"J Biol Chem"},{"issue":"8","key":"12_CR101","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bbagrm.2014.02.015","volume":"1839","author":"S Gayatri","year":"2014","unstructured":"Gayatri S, Bedford MT (2014) Readers of histonemethylarginine marks. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1839(8):702\u2013710","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"issue":"1","key":"12_CR102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41375-018-0165-2","volume":"33","author":"C Gebhard","year":"2019","unstructured":"Gebhard C, Glatz D, Schwarzfischer L, Wimmer J, Stasik S, Nuetzel M et al (2019) Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association. Leukemia 33(1):26\u201336","journal-title":"Leukemia"},{"issue":"26","key":"12_CR103","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF et al (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371(26):2477\u20132487","journal-title":"N Engl J Med"},{"issue":"6","key":"12_CR104","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.31557\/APJCP.2019.20.6.1691","volume":"20","author":"JA Gilani","year":"2019","unstructured":"Gilani JA, Ashfaq MA, Jabbar AA, Siddiqui T, Khan M (2019) Overview of the mutational landscape in primary myelofibrosis and advances in novel therapeutics. Asian Pacific Journal of Cancer Prevention: APJCP 20(6):1691","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP"},{"issue":"3","key":"12_CR105","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/onc.2015.92","volume":"35","author":"G Giotopoulos","year":"2016","unstructured":"Giotopoulos G, Chan WI, Horton SJ, Ruau D, Gallipoli P, Fowler A et al (2016) The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia. Oncogene 35(3):279\u2013289","journal-title":"Oncogene"},{"issue":"6","key":"12_CR106","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.cell.2015.05.012","volume":"161","author":"S Gkountela","year":"2015","unstructured":"Gkountela S, Zhang KX, Shafiq TA, Liao WW, Hargan-Calvopi\u00f1a J, Chen PY, Clark AT (2015) DNA demethylation dynamics in the human prenatal germline. Cell 161(6):1425\u20131436","journal-title":"Cell"},{"issue":"9","key":"12_CR107","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.molcel.2023.03.018","volume":"83","author":"E Glancy","year":"2023","unstructured":"Glancy E, Wang C, Tuck E, Healy E, Amato S, Neikes HK et al (2023) PRC2. 1-and PRC2. 2-specific accessory proteins drive recruitment of different forms of canonical PRC1. Mol Cell 83(9):1393\u20131411","journal-title":"Mol Cell"},{"issue":"2","key":"12_CR108","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.bneo.2025.100089","volume":"2","author":"LA Goldberg","year":"2025","unstructured":"Goldberg LA, Yoon JJ, Johnston H, Davidson MB, Siddon A, Shallis RM et al (2025) Response and outcomes of patients with IDH1\/2-mutated accelerated\/blast-phase myeloproliferative neoplasms. Blood Neoplasia 2(2):100089","journal-title":"Blood Neoplasia"},{"key":"12_CR109","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fgene.2019.00133","volume":"10","author":"SL Goldman","year":"2019","unstructured":"Goldman SL, Hassan C, Khunte M, Soldatenko A, Jong Y, Afshinnekoo E, Mason CE (2019) Epigenetic modifications in acute myeloid leukemia: prognosis, treatment, and heterogeneity. Front Genet 10:133","journal-title":"Front Genet"},{"key":"12_CR110","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mrrev.2017.09.003","volume":"780","author":"F Gong","year":"2019","unstructured":"Gong F, Miller KM (2019) Histone methylation and the DNA damage response. Mutation Research\/Reviews in Mutation Research 780:37\u201347","journal-title":"Mutation Research\/Reviews in Mutation Research"},{"issue":"9","key":"12_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12074","volume":"11","author":"A G\u00f3rska","year":"2021","unstructured":"G\u00f3rska A, Jab\u0142o\u0144ska E, Reszka E, Niedoszytko M, Lange M, Grucha\u0142a-Niedoszytko M et al (2021) DNA methylation profile in patients with indolent systemic mastocytosis. Clin Transl Allergy 11(9):e12074","journal-title":"Clin Transl Allergy"},{"key":"12_CR112","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S2152-2650(21)01197-6","volume":"21","author":"J Gotlib","year":"2021","unstructured":"Gotlib J, Shomali W, Reiter A (2021) Chronic Eosinophilic Leukemia: Diagnosis and Therapy. Clinical Lymphoma Myeloma and Leukemia 21:S27\u2013S29","journal-title":"Clinical Lymphoma Myeloma and Leukemia"},{"issue":"2","key":"12_CR113","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2016.03.014","volume":"62","author":"A Goudarzi","year":"2016","unstructured":"Goudarzi A, Zhang D, Huang H, Barral S, Kwon OK, Qi S et al (2016) Dynamic competing histone H4 K5K8 acetylation and butyrylation are hallmarks of highly active gene promoters. Mol Cell 62(2):169\u2013180","journal-title":"Mol Cell"},{"issue":"4","key":"12_CR114","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/nar\/gkl002","volume":"34","author":"R Goyal","year":"2006","unstructured":"Goyal R, Reinhardt R, Jeltsch A (2006) Accuracy of DNA methylation pattern preservation by the Dnmt1 methyltransferase. Nucleic Acids Res 34(4):1182\u20131188","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"12_CR115","first-page":"543","volume":"2011","author":"T Graubert","year":"2011","unstructured":"Graubert T, Walter MJ (2011) Genetics of myelodysplastic syndromes: new insights. Hematology 2010, the American Society of Hematology Education Program Book 2011(1):543\u2013549","journal-title":"Hematology 2010, the American Society of Hematology Education Program Book"},{"issue":"6649","key":"12_CR116","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389(6649):349\u2013352","journal-title":"Nature"},{"issue":"1","key":"12_CR117","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.seminhematol.2024.01.013","volume":"61","author":"L Guarnera","year":"2024","unstructured":"Guarnera L, Jha BK (2024) TET2 mutation as prototypic clonal hematopoiesis lesion. In Seminars in hematology 61(1):51\u201360. WB Saunders","journal-title":"In Seminars in hematology"},{"issue":"3","key":"12_CR118","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ajh.27553","volume":"100","author":"H Guerineau","year":"2025","unstructured":"Guerineau H, Cayuela JM, Dulucq S, Quang VT, Tarfi S, Gricourt G et al (2025) Mutation of epigenetic regulators at diagnosis is an independent predictor of tyrosine kinase inhibitor treatment failure in chronic myeloid leukemia: a report from the RESIDIAG study. Am J Hematol 100(3):507\u2013510","journal-title":"Am J Hematol"},{"issue":"19","key":"12_CR119","first-page":"5227","volume":"118","author":"P Guglielmelli","year":"2011","unstructured":"Guglielmelli P, Biamonte F, Score J, Hidalgo-Curtis C, Cervantes F, Maffioli M et al (2011) EZH2 mutational status predicts poor survival in myelofibrosis. Blood, The Journal of the American Society of Hematology 118(19):5227\u20135234","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"3","key":"12_CR120","doi-asserted-by":"publisher","first-page":"e1001354","DOI":"10.1371\/journal.pgen.1001354","volume":"7","author":"B Guillemette","year":"2011","unstructured":"Guillemette B, Drogaris P, Lin HHS, Armstrong H, Hiragami-Hamada K, Imhof A, Festenstein RJ (2011) H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet 7(3):e1001354","journal-title":"PLoS Genet"},{"issue":"3","key":"12_CR121","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/joim.12410","volume":"279","author":"T G\u00fclen","year":"2016","unstructured":"G\u00fclen T, H\u00e4gglund H, Dahl\u00e9n B, Nilsson G (2016) Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med 279(3):211\u2013228","journal-title":"J Intern Med"},{"issue":"1","key":"12_CR122","first-page":"1","volume":"11","author":"AK Gupta","year":"2021","unstructured":"Gupta AK, Meena JP, Chopra A, Tanwar P, Seth R (2021) Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management. Am J Blood Res 11(1):1","journal-title":"Am J Blood Res"},{"issue":"1","key":"12_CR123","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12185-021-03210-x","volume":"115","author":"W Han","year":"2022","unstructured":"Han W, Zhou F, Wang Z, Hua H, Qin W, Jia Z et al (2022) Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance. Int J Hematol 115(1):21\u201332","journal-title":"Int J Hematol"},{"issue":"5","key":"12_CR124","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3324\/haematol.2013.095133","volume":"99","author":"K Hanssens","year":"2014","unstructured":"Hanssens K, Brenet F, Agopian J, Georgin-Lavialle S, Damaj G, Cabaret L et al (2014) SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes. Haematologica 99(5):830","journal-title":"Haematologica"},{"issue":"4","key":"12_CR125","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","volume":"21","author":"WJ Harris","year":"2012","unstructured":"Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y et al (2012) The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 21(4):473\u2013487","journal-title":"Cancer Cell"},{"issue":"26","key":"12_CR126","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood.2023020078","volume":"142","author":"RP Hasserjian","year":"2023","unstructured":"Hasserjian RP, Germing U, Malcovati L (2023) Diagnosis and classification of myelodysplastic syndromes. Blood 142(26):2247\u20132257","journal-title":"Blood"},{"key":"12_CR127","doi-asserted-by":"crossref","unstructured":"Hata K, Okano M, Lei H & Li E (2002) Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice.","DOI":"10.1242\/dev.129.8.1983"},{"issue":"2","key":"12_CR128","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2020.03.004","volume":"78","author":"SA Haws","year":"2020","unstructured":"Haws SA, Yu D, Ye C, Wille CK, Nguyen LC, Krautkramer KA et al (2020) Methyl-metabolite depletion elicits adaptive responses to support heterochromatin stability and epigenetic persistence. Mol Cell 78(2):210\u2013223","journal-title":"Mol Cell"},{"issue":"6047","key":"12_CR129","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"YF He","year":"2011","unstructured":"He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q et al (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333(6047):1303\u20131307","journal-title":"Science"},{"issue":"9","key":"12_CR130","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2016.143","volume":"30","author":"G Heller","year":"2016","unstructured":"Heller G, Topakian T, Altenberger C, Cerny-Reiterer S, Herndlhofer S, Ziegler B et al (2016) Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia. Leukemia 30(9):1861\u20131868","journal-title":"Leukemia"},{"issue":"46","key":"12_CR131","doi-asserted-by":"publisher","first-page":"48350","DOI":"10.1074\/jbc.M403427200","volume":"279","author":"A Hermann","year":"2004","unstructured":"Hermann A, Goyal R, Jeltsch A (2004) The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J Biol Chem 279(46):48350\u201348359","journal-title":"J Biol Chem"},{"issue":"12","key":"12_CR132","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.18632\/oncotarget.733","volume":"3","author":"H Herrmann","year":"2012","unstructured":"Herrmann H, Blatt K, Shi J, Gleixner KV, Cerny-Reiterer S, M\u00fcllauer L et al (2012) Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem-and progenitor cells in acute myeloid leukemia (AML). Oncotarget 3(12):1588","journal-title":"Oncotarget"},{"issue":"3","key":"12_CR133","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.beha.2020.101199","volume":"33","author":"CE Hershberger","year":"2020","unstructured":"Hershberger CE, Daniels NJ, Padgett RA (2020) Spliceosomal factor mutations and mis-splicing in MDS. Best Practice & Research Clinical Haematology 33(3):101199","journal-title":"Best Practice & Research Clinical Haematology"},{"issue":"2","key":"12_CR134","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/bjh.18834","volume":"202","author":"A Hinze","year":"2023","unstructured":"Hinze A, Rinke J, Crodel CC, M\u00f6bius S, Sch\u00e4fer V, Heidel FH et al (2023) Molecular-defined clonal evolution in patients with classical myeloproliferative neoplasms. Br J Haematol 202(2):308\u2013317","journal-title":"Br J Haematol"},{"issue":"4","key":"12_CR135","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","volume":"34","author":"A Hochhaus","year":"2020","unstructured":"Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F et al (2020) European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia 34(4):966\u2013984","journal-title":"Leukemia"},{"issue":"6","key":"12_CR136","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.molonc.2012.07.004","volume":"6","author":"I Hoffmann","year":"2012","unstructured":"Hoffmann I, Roatsch M, Schmitt ML, Carlino L, Pippel M, Sippl W, Jung M (2012) The role of histone demethylases in cancer therapy. Mol Oncol 6(6):683\u2013703","journal-title":"Mol Oncol"},{"issue":"8","key":"12_CR137","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","volume":"28","author":"D Hormaechea-Agulla","year":"2021","unstructured":"Hormaechea-Agulla D, Matatall KA, Le DT, Kain B, Long X, Kus P et al (2021) Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN\u03b3 signaling. Cell Stem Cell 28(8):1428\u20131442","journal-title":"Cell Stem Cell"},{"issue":"7576","key":"12_CR138","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15713","volume":"527","author":"L Hu","year":"2015","unstructured":"Hu L, Lu J, Cheng J, Rao Q, Li Z, Hou H et al (2015) Structural insight into substrate preference for TET-mediated oxidation. Nature 527(7576):118\u2013122","journal-title":"Nature"},{"issue":"11","key":"12_CR139","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/s41477-024-01821-w","volume":"10","author":"P Hu","year":"2024","unstructured":"Hu P, Xu Y, Su Y, Wang Y, Xiong Y, Ding Y (2024) Nuclear-localized pyruvate kinases control phosphorylation of histone H3 on threonine 11. Nature Plants 10(11):1682\u20131697","journal-title":"Nature Plants"},{"issue":"12","key":"12_CR140","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1038\/s41375-022-01734-7","volume":"36","author":"S Huber","year":"2022","unstructured":"Huber S, Haferlach T, Meggendorfer M, Hutter S, Hoermann G, Baer C et al (2022) SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase. Leukemia 36(12):2927\u20132930","journal-title":"Leukemia"},{"key":"12_CR141","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1182\/blood-2024-200561","volume":"144","author":"S Huber","year":"2024","unstructured":"Huber S, Hutter S, Baer CR, Meggendorfer M, Hoermann G, Kern W et al (2024) Similarities and Differences of DNMT3A, TET2 and ASXL1 Mutations across Ccus, MDS and AML. Blood 144:1819","journal-title":"Blood"},{"issue":"24","key":"12_CR142","doi-asserted-by":"publisher","first-page":"16575","DOI":"10.1074\/jbc.M109.005421","volume":"284","author":"PJ Hurd","year":"2009","unstructured":"Hurd PJ, Bannister AJ, Halls K, Dawson MA, Vermeulen M, Olsen JV et al (2009) Phosphorylation of Histone H3 Thr-45 Is Linked to Apoptosis*\u2666. J Biol Chem 284(24):16575\u201316583","journal-title":"J Biol Chem"},{"issue":"5","key":"12_CR143","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","volume":"53","author":"JW Hwang","year":"2021","unstructured":"Hwang JW, Cho Y, Bae GU, Kim SN, Kim YK (2021) Protein arginine methyltransferases: promising targets for cancer therapy. Exp Mol Med 53(5):788\u2013808","journal-title":"Exp Mol Med"},{"issue":"4","key":"12_CR144","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1038\/emm.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K, Jeon J, Park K, Kim J (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49(4):e324\u2013e324","journal-title":"Exp Mol Med"},{"issue":"8","key":"12_CR145","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3324\/haematol.2018.200832","volume":"104","author":"JC Ianotto","year":"2019","unstructured":"Ianotto JC, Curto-Garcia N, Lauermanova M, Radia D, Kiladjian JJ, Harrison CN (2019) Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. Haematologica 104(8):1580","journal-title":"Haematologica"},{"issue":"24","key":"12_CR146","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1128\/MCB.00757-15","volume":"35","author":"M Ikura","year":"2015","unstructured":"Ikura M, Furuya K, Matsuda S, Matsuda R, Shima H, Adachi J et al (2015) Acetylation of histone H2AX at Lys 5 by the TIP60 histone acetyltransferase complex is essential for the dynamic binding of NBS1 to damaged chromatin. Mol Cell Biol 35(24):4147\u20134157","journal-title":"Mol Cell Biol"},{"issue":"4","key":"12_CR147","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1021\/cb600188m","volume":"1","author":"JA I\u00f1iguez-Lluh\u00ed","year":"2006","unstructured":"I\u00f1iguez-Lluh\u00ed JA (2006) For a healthy histone code, a little SUMO in the tail keeps the acetyl away. ACS Chem Biol 1(4):204\u2013206","journal-title":"ACS Chem Biol"},{"issue":"2","key":"12_CR148","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.hoc.2010.02.007","volume":"24","author":"JP Issa","year":"2010","unstructured":"Issa JP (2010) Epigenetic changes in the myelodysplastic syndrome. Hematol Oncol Clin North Am 24(2):317","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"12_CR149","first-page":"2075","volume":"93","author":"JPJ Issa","year":"1999","unstructured":"Issa JPJ, Kantarjian H, Mohan A, O\u2019Brien S, Cortes J, Pierce S, Talpaz M (1999) Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance. Blood, The Journal of the American Society of Hematology 93(6):2075\u20132080","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6047","key":"12_CR150","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA et al (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047):1300\u20131303","journal-title":"Science"},{"issue":"3","key":"12_CR151","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/leu.2013.343","volume":"28","author":"R Itzykson","year":"2014","unstructured":"Itzykson R, Fenaux P (2014) Epigenetics of myelodysplastic syndromes. Leukemia 28(3):497\u2013506","journal-title":"Leukemia"},{"issue":"9","key":"12_CR152","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.26642","volume":"97","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Kantarjian H (2022) Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol 97(9):1236\u20131256","journal-title":"Am J Hematol"},{"key":"12_CR153","doi-asserted-by":"crossref","unstructured":"Jabbour E & Kantarjian H (2025) Chronic myeloid leukemia: a review. JAMA.","DOI":"10.1001\/jama.2025.0220"},{"issue":"2","key":"12_CR154","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E et al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med 377(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"7037","key":"12_CR155","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP, Staerk J, Delhommeau F, Lacout C et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144\u20131148","journal-title":"Nature"},{"issue":"14","key":"12_CR156","first-page":"3932","volume":"118","author":"AM Jankowska","year":"2011","unstructured":"Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F et al (2011) Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood, The Journal of the American Society of Hematology 118(14):3932\u20133941","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"7","key":"12_CR157","doi-asserted-by":"publisher","first-page":"e22110","DOI":"10.1371\/journal.pone.0022110","volume":"6","author":"J Jelinek","year":"2011","unstructured":"Jelinek J, Gharibyan V, Estecio MR, Kondo K, He R, Chung W et al (2011) Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One 6(7):e22110","journal-title":"PLoS One"},{"issue":"12","key":"12_CR158","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1093\/nar\/gkz309","volume":"47","author":"JH Ji","year":"2019","unstructured":"Ji JH, Min S, Chae S, Ha GH, Kim Y, Park YJ et al (2019) De novo phosphorylation of H2AX by WSTF regulates transcription-coupled homologous recombination repair. Nucleic Acids Res 47(12):6299\u20136314","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"12_CR159","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s12094-021-02585-x","volume":"23","author":"J Jian","year":"2021","unstructured":"Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B (2021) Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clin Transl Oncol 23(9):1731\u20131742","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"12_CR160","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s10238-022-00980-4","volume":"23","author":"J Jian","year":"2023","unstructured":"Jian J, Yuan C, Ji C, Hao H, Lu F (2023) DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features. Clin Exp Med 23(6):2639\u20132649","journal-title":"Clin Exp Med"},{"issue":"1","key":"12_CR161","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1073\/pnas.0606775103","volume":"104","author":"T Jiang","year":"2007","unstructured":"Jiang T, Zhou X, Taghizadeh K, Dong M, Dedon PC (2007) N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage. Proceedings of the National Academy of Sciences 104(1):60\u201365","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"12_CR162","first-page":"1315","volume":"113","author":"Y Jiang","year":"2009","unstructured":"Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O\u2019Keefe C et al (2009) Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood, The Journal of the American Society of Hematology 113(6):1315\u20131325","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"12_CR163","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-019-0090-5","volume":"5","author":"H Jiang","year":"2020","unstructured":"Jiang H, Ou Z, He Y, Yu M, Wu S, Li G et al (2020) DNA methylation markers in the diagnosis and prognosis of common leukemias. Signal Transduct Target Ther 5(1):3","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"12_CR164","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1021\/cr500457h","volume":"115","author":"H Jing","year":"2015","unstructured":"Jing H, Lin H (2015) Sirtuins in epigenetic regulation. Chem Rev 115(6):2350\u20132375","journal-title":"Chem Rev"},{"issue":"12","key":"12_CR165","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/s12276-020-00539-x","volume":"52","author":"C Jo","year":"2020","unstructured":"Jo C, Park S, Oh S, Choi J, Kim EK, Youn HD, Cho EJ (2020) Histone acylation marks respond to metabolic perturbations and enable cellular adaptation. Exp Mol Med 52(12):2005\u20132019","journal-title":"Exp Mol Med"},{"issue":"5","key":"12_CR166","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1097\/HS9.0000000000000292","volume":"3","author":"SM Johnson","year":"2019","unstructured":"Johnson SM, Richardson DR, Galeotti J, Esparza S, Zhu A, Fedoriw Y et al (2019) Acute myeloid leukemia with co-mutated ASXL1 and SRSF2 exhibits monocytic differentiation and has a mutational profile overlapping with chronic myelomonocytic leukemia. Hemasphere 3(5):e292","journal-title":"Hemasphere"},{"issue":"4","key":"12_CR167","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128(4):683\u2013692","journal-title":"Cell"},{"issue":"5","key":"12_CR168","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/nar\/gkt012","volume":"41","author":"S J\u00f8rgensen","year":"2013","unstructured":"J\u00f8rgensen S, Schotta G, S\u00f8rensen CS (2013) Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity. Nucleic Acids Res 41(5):2797\u20132806","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"12_CR169","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2174\/138161208783885380","volume":"14","author":"M Jung","year":"2008","unstructured":"Jung M, Neugebauer RC, Sippl W (2008) Inhibitors of NAD+ dependent histone deacetylases (sirtuins). Curr Pharm Des 14(6):562\u2013573","journal-title":"Curr Pharm Des"},{"issue":"5","key":"12_CR170","first-page":"1164","volume":"110","author":"K Kaastrup","year":"2025","unstructured":"Kaastrup K, Tulstrup M, Hansen JW, Sch\u00f6llkopf C, Raaschou-Jensen K, \u00d8rskov AD et al (2025) Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations. Haematologica 110(5):1164","journal-title":"Haematologica"},{"issue":"4","key":"12_CR171","doi-asserted-by":"publisher","first-page":"a035675","DOI":"10.1101\/cshperspect.a035675","volume":"10","author":"J Kaner","year":"2020","unstructured":"Kaner J, Desai P, Mencia-Trinchant N, Guzman ML, Roboz GJ, Hassane DC (2020) Clonal hematopoiesis and premalignant diseases. Cold Spring Harbor Perspect Med 10(4):a035675","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"12","key":"12_CR172","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nsmb.2912","volume":"21","author":"T Kanno","year":"2014","unstructured":"Kanno T, Kanno Y, LeRoy G, Campos E, Sun HW, Brooks SR et al (2014) BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol 21(12):1047\u20131057","journal-title":"Nat Struct Mol Biol"},{"issue":"21","key":"12_CR173","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood.2024027999","volume":"145","author":"D Karpova","year":"2025","unstructured":"Karpova D, Huerga Encabo H, Donato E, Calderazzo S, Scherer M, Llorian-Sopena M et al (2025) Clonal hematopoiesis landscape in frequent blood donors. Blood 145(21):2411\u20132423","journal-title":"Blood"},{"issue":"26","key":"12_CR174","first-page":"10","volume":"4","author":"MA Keller","year":"2024","unstructured":"Keller MA, Nakamura M (2024) Acetyltransferase in cardiovascular disease and aging. The journal of cardiovascular aging 4(26):10\u201320517","journal-title":"The journal of cardiovascular aging"},{"issue":"1","key":"12_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49071-w","volume":"15","author":"JL Kelliher","year":"2024","unstructured":"Kelliher JL, Folkerts ML, Shen KV, Song W, Tengler K, Stiefel CM et al (2024) Evolved histone tail regulates 53BP1 recruitment at damaged chromatin. Nat Commun 15(1):4634","journal-title":"Nat Commun"},{"issue":"9","key":"12_CR176","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1200\/JCO.2016.71.0806","volume":"35","author":"JA Kennedy","year":"2017","unstructured":"Kennedy JA, Ebert BL (2017) Clinical implications of genetic mutations in myelodysplastic syndrome. J Clin Oncol 35(9):968\u2013974","journal-title":"J Clin Oncol"},{"issue":"1","key":"12_CR177","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.seminhematol.2013.01.001","volume":"50","author":"H Khan","year":"2013","unstructured":"Khan H, Vale C, Bhagat T, Verma A (2013) Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes. In Seminars in hematology 50(1):16\u201337. WB Saunders","journal-title":"In Seminars in hematology"},{"issue":"5","key":"12_CR178","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","volume":"27","author":"E Kim","year":"2015","unstructured":"Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SCW, Ramakrishnan A et al (2015) SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 27(5):617\u2013630","journal-title":"Cancer Cell"},{"issue":"1","key":"12_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00941-2","volume":"12","author":"D Komar","year":"2020","unstructured":"Komar D, Juszczynski P (2020) Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy. Clin Epigenetics 12(1):147","journal-title":"Clin Epigenetics"},{"key":"12_CR180","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2017.07.006","volume":"51","author":"S Koschmieder","year":"2018","unstructured":"Koschmieder S, Vetrie D (2018, August) Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options. In Seminars in Cancer Biology 51:180\u2013197. Academic Press","journal-title":"In Seminars in Cancer Biology"},{"issue":"4","key":"12_CR181","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693\u2013705","journal-title":"Cell"},{"key":"12_CR182","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.3389\/fimmu.2018.02414","volume":"9","author":"D Krajewski","year":"2018","unstructured":"Krajewski D, Kaczenski E, Rovatti J, Polukort S, Thompson C, Dollard C et al (2018) Epigenetic regulation via altered histone acetylation results in suppression of mast cell function and mast cell-mediated food allergic responses. Front Immunol 9:2414","journal-title":"Front Immunol"},{"issue":"17","key":"12_CR183","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352(17):1779\u20131790","journal-title":"N Engl J Med"},{"issue":"24","key":"12_CR184","doi-asserted-by":"publisher","first-page":"16066","DOI":"10.1074\/jbc.C900032200","volume":"284","author":"N Krishnan","year":"2009","unstructured":"Krishnan N, Jeong DG, Jung SK, Ryu SE, Xiao A, Allis CD et al (2009) Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A. X is mediated by the protein phosphatase eyes absent. J Biol Chem 284(24):16066\u201316070","journal-title":"J Biol Chem"},{"key":"12_CR186","doi-asserted-by":"crossref","unstructured":"Krizkova J, Polivkova V, Laznicka A, Curik N, Benesova A, Suchankova P et al (2025) Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR:: ABL1-positive acute lymphoblastic leukemia. Leukemia, 1-8.","DOI":"10.21203\/rs.3.rs-5789724\/v1"},{"issue":"3","key":"12_CR187","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0955-0674(02)00335-6","volume":"14","author":"M Lachner","year":"2002","unstructured":"Lachner M, Jenuwein T (2002) The many faces of histone lysine methylation. Curr Opin Cell Biol 14(3):286\u2013298","journal-title":"Curr Opin Cell Biol"},{"issue":"8","key":"12_CR188","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrc3091","volume":"11","author":"AY Lai","year":"2011","unstructured":"Lai AY, Wade PA (2011) NuRD: A multi-faceted chromatin remodeling complex in regulating cancer biology. Nat Rev Cancer 11(8):588","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"12_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56781-2","volume":"16","author":"F Lang","year":"2025","unstructured":"Lang F, Kaur K, Fu H, Zaheer J, Ribeiro DL, Aladjem MI, Yang C (2025) D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming. Nat Commun 16(1):1431","journal-title":"Nat Commun"},{"issue":"7","key":"12_CR190","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SM Langemeijer","year":"2009","unstructured":"Langemeijer SM, Kuiper RP, Berends M, Knops R, Aslanyan MG, Massop M et al (2009) Acquired mutations in TET2 are common in myelodysplastic syndromes. Nature Genet 41(7):838\u2013842","journal-title":"Nature Genet"},{"key":"12_CR191","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood-2023-178083","volume":"142","author":"TL Lasho","year":"2023","unstructured":"Lasho TL, Finke CM, Fernandez JA, Schmitz CT, Clark KJ, Wahlestedt C et al (2023) Targeting Oncogenic Enhancers in ASXL1-Mutant Chronic Myelomonocytic Leukemia. Blood 142:1413","journal-title":"Blood"},{"issue":"1","key":"12_CR192","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13039-025-00712-9","volume":"18","author":"C Lauzon-Young","year":"2025","unstructured":"Lauzon-Young C, Silva A, Sadikovic B (2025) Epigenomic insights and computational advances in hematologic malignancies. Mol Cytogenet 18(1):9","journal-title":"Mol Cytogenet"},{"issue":"1","key":"12_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09624-w","volume":"10","author":"E Lavarone","year":"2019","unstructured":"Lavarone E, Barbieri CM, Pasini D (2019) Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity. Nat Commun 10(1):1679","journal-title":"Nat Commun"},{"issue":"14","key":"12_CR194","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/cancers13143587","volume":"13","author":"B Lebecque","year":"2021","unstructured":"Lebecque B, Bourgne C, Vidal V, Berger MG (2021) DNA methylation and intra-clonal heterogeneity: The chronic myeloid leukemia model. Cancers 13(14):3587","journal-title":"Cancers"},{"issue":"8","key":"12_CR195","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1616420114","volume":"114","author":"C Leoni","year":"2017","unstructured":"Leoni C, Montagner S, Rinaldi A, Bertoni F, Polletti S, Balestrieri C, Monticelli S (2017) Dnmt3a restrains mast cell inflammatory responses. Proceedings of the national academy of sciences 114(8):E1490\u2013E1499","journal-title":"Proceedings of the national academy of sciences"},{"issue":"4","key":"12_CR196","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7(4):387\u2013397","journal-title":"Cancer Cell"},{"issue":"25","key":"12_CR197","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al (2010) DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363(25):2424\u20132433","journal-title":"N Engl J Med"},{"issue":"5","key":"12_CR198","doi-asserted-by":"publisher","first-page":"a019133","DOI":"10.1101\/cshperspect.a019133","volume":"6","author":"E Li","year":"2014","unstructured":"Li E, Zhang Y (2014) DNA methylation in mammals. Cold Spring Harbor Perspect Biol 6(5):a019133","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"15","key":"12_CR199","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s00018-019-03144-y","volume":"76","author":"J Li","year":"2019","unstructured":"Li J, Ahn JH, Wang GG (2019) Understanding histone H3 lysine 36 methylation and its deregulation in disease. Cell Mol Life Sci 76(15):2899\u20132916","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"12_CR200","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1080\/07853890.2022.2099578","volume":"54","author":"M Li","year":"2022","unstructured":"Li M, Zhang D (2022) DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation. Ann Med 54(1):2011\u20132023","journal-title":"Ann Med"},{"issue":"2","key":"12_CR201","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cell.2008.06.018","volume":"134","author":"Q Li","year":"2008","unstructured":"Li Q, Zhou H, Wurtele H, Davies B, Horazdovsky B, Verreault A, Zhang Z (2008) Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell 134(2):244\u2013255","journal-title":"Cell"},{"key":"12_CR202","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.freeradbiomed.2025.01.019","volume":"228","author":"Y Li","year":"2025","unstructured":"Li Y, Dong X, Xing H, Liu W, Gu R, Qiu S et al (2025) U2AF1 mutation causes an oxidative stress and DNA repair defect in hematopoietic and leukemic cells. Free Radic Biol Med 228:379\u2013391","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"12_CR203","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.molcel.2016.03.028","volume":"62","author":"Y Li","year":"2016","unstructured":"Li Y, Sabari BR, Panchenko T, Wen H, Zhao D, Guan H et al (2016) Molecular coupling of histone crotonylation and active transcription by AF9 YEATS domain. Mol Cell 62(2):181\u2013193","journal-title":"Mol Cell"},{"issue":"1","key":"12_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02177-w","volume":"8","author":"DB Lipka","year":"2017","unstructured":"Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, N\u00f6llke P et al (2017) RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun 8(1):2126","journal-title":"Nat Commun"},{"issue":"2","key":"12_CR205","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/BSR20080176","volume":"29","author":"M Litt","year":"2009","unstructured":"Litt M, Qiu Y, Huang S (2009) Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation. Biosci Rep 29(2):131\u2013141","journal-title":"Biosci Rep"},{"issue":"3","key":"12_CR206","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1002\/mco2.292","volume":"4","author":"R Liu","year":"2023","unstructured":"Liu R, Wu J, Guo H, Yao W, Li S, Lu Y et al (2023) Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 4(3):e292","journal-title":"MedComm"},{"issue":"14","key":"12_CR207","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341(14):1051\u20131062","journal-title":"N Engl J Med"},{"issue":"7390","key":"12_CR208","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature10860","volume":"483","author":"C Lu","year":"2012","unstructured":"Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O et al (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483(7390):474\u2013478","journal-title":"Nature"},{"issue":"11","key":"12_CR209","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tibs.2013.08.002","volume":"38","author":"R Lu","year":"2013","unstructured":"Lu R, Wang GG (2013) Tudor: a versatile family of histone methylation \u2018readers\u2019. Trends Biochem Sci 38(11):546\u2013555","journal-title":"Trends Biochem Sci"},{"issue":"16","key":"12_CR210","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood.2022017578","volume":"141","author":"D Luque Paz","year":"2023","unstructured":"Luque Paz D, Kralovics R, Skoda RC (2023) Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood 141(16):1909\u20131921","journal-title":"Blood"},{"issue":"7","key":"12_CR211","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.04.014","volume":"125","author":"X Ma","year":"2012","unstructured":"Ma X (2012) Epidemiology of myelodysplastic syndromes. Am J Med 125(7):S2\u2013S5","journal-title":"Am J Med"},{"issue":"1","key":"12_CR212","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11899-012-0152-z","volume":"8","author":"K Machova Polakova","year":"2013","unstructured":"Machova Polakova K, Koblihova J, Stopka T (2013) Role of epigenetics in chronic myeloid leukemia. Current hematologic malignancy reports 8(1):28\u201336","journal-title":"Current hematologic malignancy reports"},{"key":"12_CR213","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fonc.2018.00255","volume":"8","author":"D Magliulo","year":"2018","unstructured":"Magliulo D, Bernardi R, Messina S (2018) Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia. Front Oncol 8:255","journal-title":"Front Oncol"},{"issue":"2","key":"12_CR214","first-page":"157","volume":"136","author":"L Malcovati","year":"2020","unstructured":"Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J et al (2020) SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood, Am Soc Hemato 136(2):157\u2013170","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"12_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00468-7","volume":"11","author":"M Mancini","year":"2023","unstructured":"Mancini M, Monaldi C, De Santis S, Papayannidis C, Rondoni M, Sartor C et al (2023) SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A\/MDM2 axis and can be therapeutically targeted. Biomark Res 11(1):29","journal-title":"Biomark Res"},{"issue":"5","key":"12_CR216","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3324\/haematol.2021.280463","volume":"107","author":"AA Mangaonkar","year":"2022","unstructured":"Mangaonkar AA, Lasho TL, Finke C, Ketterling RP, Reichard KK, McCullough K et al (2022) SF3B1-mutant myelodysplastic syndrome\/myeloproliferative neoplasms: a unique molecular and prognostic entity. Haematologica 107(5):1189","journal-title":"Haematologica"},{"issue":"1","key":"12_CR217","first-page":"22","volume":"110","author":"L Marando","year":"2024","unstructured":"Marando L, Csizmar CM, Patnaik MM (2024) Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations. Haematologica 110(1):22","journal-title":"Haematologica"},{"issue":"1","key":"12_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-025-01003-7","volume":"9","author":"HE Marei","year":"2025","unstructured":"Marei HE (2025) Epigenetic regulators in cancer therapy and progression. NPJ Precision Oncology 9(1):1\u201318","journal-title":"NPJ Precision Oncology"},{"issue":"3","key":"12_CR219","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/jmbi.2001.4859","volume":"311","author":"R Marmorstein","year":"2001","unstructured":"Marmorstein R (2001) Structure of histone acetyltransferases. J Mol Biol 311(3):433\u2013444","journal-title":"J Mol Biol"},{"issue":"7","key":"12_CR220","doi-asserted-by":"publisher","first-page":"a018762","DOI":"10.1101\/cshperspect.a018762","volume":"6","author":"R Marmorstein","year":"2014","unstructured":"Marmorstein R, Zhou MM (2014) Writers and readers of histone acetylation: structure, mechanism, and inhibition. Cold Spring Harbor Perspect Biol 6(7):a018762","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"12_CR221","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2021.07.004","volume":"161","author":"CS Marnell","year":"2021","unstructured":"Marnell CS, Bick A, Natarajan P (2021) Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol 161:98\u2013105","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"12_CR222","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/leu.2017.183","volume":"32","author":"G Martinelli","year":"2018","unstructured":"Martinelli G, Mancini M, De Benedittis C, Rondoni M, Papayannidis C, Manfrini M et al (2018) SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis. Leukemia 32(1):139\u2013148","journal-title":"Leukemia"},{"issue":"7048","key":"12_CR223","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03714","volume":"436","author":"H Masumoto","year":"2005","unstructured":"Masumoto H, Hawke D, Kobayashi R, Verreault A (2005) A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature 436(7048):294\u2013298","journal-title":"Nature"},{"issue":"6","key":"12_CR224","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","volume":"37","author":"F Mattiroli","year":"2021","unstructured":"Mattiroli F, Penengo L (2021) Histone ubiquitination: an integrative signaling platform in genome stability. TIG 37(6):566\u2013581","journal-title":"TIG"},{"issue":"6","key":"12_CR225","first-page":"715","volume":"129","author":"JE Maxson","year":"2017","unstructured":"Maxson JE, Tyner JW (2017) Genomics of chronic neutrophilic leukemia. Blood, The Journal of the American Society of Hematology 129(6):715\u2013722","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"12_CR226","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43697-y","volume":"14","author":"J McClatchy","year":"2023","unstructured":"McClatchy J, Strogantsev R, Wolfe E, Lin HY, Mohammadhosseini M, Davis BA et al (2023) Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells. Nat Commun 14(1):8102","journal-title":"Nat Commun"},{"issue":"9","key":"12_CR227","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/jcmm.13095","volume":"21","author":"S McPherson","year":"2017","unstructured":"McPherson S, McMullin MF, Mills K (2017) Epigenetics in myeloproliferative neoplasms. J Cell Mol Med 21(9):1660\u20131667","journal-title":"J Cell Mol Med"},{"issue":"5","key":"12_CR228","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.3324\/haematol.2017.183160","volume":"103","author":"M Meggendorfer","year":"2018","unstructured":"Meggendorfer M, Jeromin S, Haferlach C, Kern W, Haferlach T (2018) The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic\/myeloproliferative neoplasms. Haematologica 103(5):e192","journal-title":"Haematologica"},{"key":"12_CR229","doi-asserted-by":"crossref","unstructured":"Menezes J & Cigudosa JC (2015) Chronic neutrophilic leukemia: a clinical perspective. Onco Targets Ther 2383-2390.","DOI":"10.2147\/OTT.S49688"},{"issue":"11","key":"12_CR230","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1038\/bcj.2013.55","volume":"3","author":"J Menezes","year":"2013","unstructured":"Menezes J, Makishima H, Gomez I, Acquadro F, Gomez-Lopez G, Grana O et al (2013) CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia. Blood Cancer J 3(11):e158\u2013e158","journal-title":"Blood Cancer J"},{"issue":"3","key":"12_CR231","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tcb.2024.08.005","volume":"35","author":"Y Meng","year":"2025","unstructured":"Meng Y, Nerlov C (2025) Epigenetic regulation of hematopoietic stem cell fate. Trends Cell Biol 35(3):217\u2013229","journal-title":"Trends Cell Biol"},{"issue":"7","key":"12_CR232","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nm0795-686","volume":"1","author":"A Merlo","year":"1995","unstructured":"Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC et al (1995) 5\u2032 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers. Nature Med 1(7):686\u2013692","journal-title":"Nature Med"},{"issue":"26","key":"12_CR233","first-page":"6920","volume":"118","author":"KH Metzeler","year":"2011","unstructured":"Metzeler KH, Becker H, Maharry K, Radmacher MD, Kohlschmidt J, Mr\u00f3zek K et al (2011) ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. Blood, The Journal of the American Society of Hematology 118(26):6920\u20136929","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"7289","key":"12_CR234","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nature08839","volume":"464","author":"E Metzger","year":"2010","unstructured":"Metzger E, Imhof A, Patel D, Kahl P, Hoffmeyer K, Friedrichs N et al (2010) Phosphorylation of histone H3T6 by PKC\u03b2I controls demethylation at histone H3K4. Nature 464(7289):792\u2013796","journal-title":"Nature"},{"issue":"1","key":"12_CR235","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ncb1668","volume":"10","author":"E Metzger","year":"2008","unstructured":"Metzger E, Yin N, Wissmann M, Kunowska N, Fischer K, Friedrichs N et al (2008) Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nature Cell Biol 10(1):53\u201360","journal-title":"Nature Cell Biol"},{"issue":"8","key":"12_CR236","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/s41375-020-0869-y","volume":"34","author":"D Midic","year":"2020","unstructured":"Midic D, Rinke J, Perner F, M\u00fcller V, Hinze A, Pester F et al (2020) Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders. Leukemia 34(8):2198\u20132205","journal-title":"Leukemia"},{"issue":"4","key":"12_CR237","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/cas.70007","volume":"116","author":"N Miyashita","year":"2025","unstructured":"Miyashita N, Onozawa M, Kasahara K, Matsukawa T, Onodera Y, Suzuki K et al (2025) CML With Mutant ASXL1 Showed Decreased Sensitivity to TKI Treatment via Upregulation of the ALOX5-BLTR Signaling Pathway. Cancer Sci 116(4):1115\u20131125","journal-title":"Cancer Sci"},{"key":"12_CR238","doi-asserted-by":"crossref","unstructured":"Mohammad A, Mascarenhas J, Marcellino BK & Nathan DI (2025) Target practice: Opportunities for therapeutic intervention in CHIP and CCUS. Blood Reviews, 101323.","DOI":"10.1016\/j.blre.2025.101323"},{"issue":"12","key":"12_CR239","doi-asserted-by":"publisher","first-page":"eadl4018","DOI":"10.1126\/sciadv.adl4018","volume":"10","author":"C Moison","year":"2024","unstructured":"Moison C, Gracias D, Schmitt J, Girard S, Spinella JF, Fortier S et al (2024) SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia. Sci Adv 10(12):eadl4018","journal-title":"Sci Adv"},{"issue":"10","key":"12_CR240","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1074\/jbc.M607909200","volume":"282","author":"SA Morris","year":"2007","unstructured":"Morris SA, Rao B, Garcia BA, Hake SB, Diaz RL, Shabanowitz J et al (2007) Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. J Biol Chem 282(10):7632\u20137640","journal-title":"J Biol Chem"},{"issue":"18","key":"12_CR241","first-page":"3564","volume":"116","author":"C M\u00fcller-Tidow","year":"2010","unstructured":"M\u00fcller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N et al (2010) Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood, The Journal of the American Society of Hematology 116(18):3564\u20133571","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"25","key":"12_CR242","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369(25):2391\u20132405","journal-title":"N Engl J Med"},{"issue":"4","key":"12_CR243","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41588-023-01348-4","volume":"55","author":"T Narita","year":"2023","unstructured":"Narita T, Higashijima Y, Kilic S, Liebner T, Walter J, Choudhary C (2023) Acetylation of histone H2B marks active enhancers and predicts CBP\/p300 target genes. Nature Genet 55(4):679\u2013692","journal-title":"Nature Genet"},{"issue":"1","key":"12_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07057-3","volume":"7","author":"HM Nielsen","year":"2017","unstructured":"Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA et al (2017) Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations. Sci Rep 7(1):6774","journal-title":"Sci Rep"},{"issue":"9","key":"12_CR245","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ni.3517","volume":"17","author":"P Ntziachristos","year":"2016","unstructured":"Ntziachristos P, Abdel-Wahab O, Aifantis I (2016) Emerging concepts of epigenetic dysregulation in hematological malignancies. Nature Immunol 17(9):1016\u20131024","journal-title":"Nature Immunol"},{"issue":"10","key":"12_CR246","first-page":"1049","volume":"133","author":"S Ogawa","year":"2019","unstructured":"Ogawa S (2019) Genetics of MDS. Blood, The Journal of the American Society of Hematology 133(10):1049\u20131059","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"12_CR247","doi-asserted-by":"publisher","first-page":"1426454","DOI":"10.3389\/fmmed.2024.1426454","volume":"4","author":"AH Nwabo Kamdje","year":"2024","unstructured":"Nwabo Kamdje AH, Dongmo Fogang HP, Mimche PN (2024) Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy. Frontiers in Molecular Medicine 4:1426454","journal-title":"Frontiers in Molecular Medicine"},{"issue":"3","key":"12_CR248","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247\u2013257","journal-title":"Cell"},{"issue":"3","key":"12_CR249","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/890","volume":"19","author":"M Okano","year":"1998","unstructured":"Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet 19(3):219\u2013220","journal-title":"Nature Genet"},{"issue":"4","key":"12_CR250","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/ejh.14149","volume":"112","author":"C O\u2019Neill","year":"2024","unstructured":"O\u2019Neill C, Nwachukwu N, Vergara-Lluri M, Hagiya A, O\u2019Connell CL (2024) Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS-IT). Eur J Haematol 112(4):594\u2013600","journal-title":"Eur J Haematol"},{"issue":"15","key":"12_CR251","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.3390\/cells11152404","volume":"11","author":"L Oss-Ronen","year":"2022","unstructured":"Oss-Ronen L, Sarusi T, Cohen I (2022) Histone mono-ubiquitination in transcriptional regulation and its mark on life: emerging roles in tissue development and disease. Cells 11(15):2404","journal-title":"Cells"},{"issue":"4","key":"12_CR252","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.stemcr.2020.02.011","volume":"14","author":"EL Ostrander","year":"2020","unstructured":"Ostrander EL, Kramer AC, Mallaney C, Celik H, Koh WK, Fairchild J et al (2020) Divergent effects of Dnmt3a and Tet2 mutations on hematopoietic progenitor cell fitness. Stem Cell Reports 14(4):551\u2013560","journal-title":"Stem Cell Reports"},{"key":"12_CR253","doi-asserted-by":"publisher","first-page":"103711","DOI":"10.1016\/j.dnarep.2024.103711","volume":"140","author":"C \u00d6zdemir","year":"2024","unstructured":"\u00d6zdemir C, Purkey LR, Sanchez A, Miller KM (2024) PARticular MARks: Histone ADP-ribosylation and the DNA damage response. DNA Repair 140:103711","journal-title":"DNA Repair"},{"issue":"9","key":"12_CR254","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/cancers13092120","volume":"13","author":"L Palomo","year":"2021","unstructured":"Palomo L, Acha P, Sol\u00e9 F (2021) Genetic aspects of myelodysplastic\/myeloproliferative neoplasms. Cancers 13(9):2120","journal-title":"Cancers"},{"issue":"1","key":"12_CR255","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/15592294.2017.1405199","volume":"13","author":"L Palomo","year":"2018","unstructured":"Palomo L, Malinverni R, Cabez\u00f3n M, Xicoy B, Arnan M, Coll R et al (2018) DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features. Epigenetics 13(1):8\u201318","journal-title":"Epigenetics"},{"issue":"16","key":"12_CR256","first-page":"1851","volume":"136","author":"L Palomo","year":"2020","unstructured":"Palomo L, Meggendorfer M, Hutter S, Twardziok S, Adem\u00e0 V, Fuhrmann I et al (2020) Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms. Blood, Am Soc Hematol 136(16):1851\u20131862","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"15","key":"12_CR257","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365(15):1384\u20131395","journal-title":"N Engl J Med"},{"key":"12_CR258","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semcancer.2021.03.015","volume":"83","author":"IG Park","year":"2022","unstructured":"Park IG, Jeon M, Kim H, Lee JM (2022, August) Coordinated methyl readers: Functional communications in cancer. In Seminars in Cancer Biology 83:88\u201399. Academic Press.","journal-title":"In Seminars in Cancer Biology"},{"issue":"2","key":"12_CR259","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"SY Park","year":"2020","unstructured":"Park SY, Kim JS (2020) A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med 52(2):204\u2013212","journal-title":"Exp Mol Med"},{"issue":"12","key":"12_CR260","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/leu.2017.164","volume":"31","author":"BJ Patel","year":"2017","unstructured":"Patel BJ, Przychodzen B, Thota S, Radivoyevitch T, Visconte V, Kuzmanovic T et al (2017) Genomic determinants of chronic myelomonocytic leukemia. Leukemia 31(12):2815\u20132823","journal-title":"Leukemia"},{"issue":"1","key":"12_CR261","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12288-019-01084-y","volume":"35","author":"H Pati","year":"2019","unstructured":"Pati H, Kundil Veetil K (2019) Myelodysplastic syndrome\/myeloproliferative neoplasm (MDS\/MPN) overlap syndromes: molecular pathogenetic mechanisms and their implications. Indian Journal of Hematology and Blood Transfusion 35(1):3\u201311","journal-title":"Indian Journal of Hematology and Blood Transfusion"},{"issue":"2","key":"12_CR262","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1038\/bcj.2016.5","volume":"6","author":"MM Patnaik","year":"2016","unstructured":"Patnaik MM, Tefferi A (2016) Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia. Blood Cancer J 6(2):e393\u2013e393","journal-title":"Blood Cancer J"},{"issue":"4","key":"12_CR263","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ajh.26828","volume":"98","author":"MM Patnaik","year":"2023","unstructured":"Patnaik MM, Tefferi A (2023) Atypical chronic myeloid leukemia and myelodysplastic\/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. Am J Hematol 98(4):681\u2013689","journal-title":"Am J Hematol"},{"issue":"6","key":"12_CR264","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ajh.27271","volume":"99","author":"MM Patnaik","year":"2024","unstructured":"Patnaik MM, Tefferi A (2024) Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol 99(6):1142\u20131165","journal-title":"Am J Hematol"},{"issue":"9","key":"12_CR265","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1038\/bcj.2016.82","volume":"6","author":"MM Patnaik","year":"2016","unstructured":"Patnaik MM, Zahid MF, Lasho TL, Finke C, Ketterling RL, Gangat N et al (2016) Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance. Blood Cancer J 6(9):e472\u2013e472","journal-title":"Blood Cancer J"},{"issue":"1","key":"12_CR266","first-page":"929840","volume":"2013","author":"A Patriarca","year":"2013","unstructured":"Patriarca A, Colaizzo D, Tiscia G, Spadano R, Di Zacomo S, Spadano A et al (2013) TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings. BioMed Res Int 2013(1):929840","journal-title":"BioMed Res Int"},{"issue":"3","key":"12_CR267","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.semdp.2023.04.005","volume":"40","author":"PP Patwardhan","year":"2023","unstructured":"Patwardhan PP, Aarabi M, Aggarwal N (2023, May) Genomics of myelodysplastic\/myeloproliferative neoplasm. In Seminars in Diagnostic Pathology 40(3):195\u2013201. . WB Saunders","journal-title":"In Seminars in Diagnostic Pathology"},{"issue":"9","key":"12_CR268","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3324\/haematol.2013.084160","volume":"98","author":"C P\u00e9rez","year":"2013","unstructured":"P\u00e9rez C, Pascual M, Mart\u00edn-Subero JI, Bellosillo B, Segura V, Delabesse E et al (2013) Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms. Haematologica 98(9):1414","journal-title":"Haematologica"},{"issue":"10","key":"12_CR269","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/bloodadvances.2023012127","volume":"8","author":"MA Perusini","year":"2024","unstructured":"Perusini MA, \u017d\u00e1\u010dkov\u00e1 D, Kim T, Pagnano K, Pavlovsky C, Je\u017e\u00ed\u0161kov\u00e1 I et al (2024) Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes. Blood Adv 8(10):2361\u20132372","journal-title":"Blood Adv"},{"issue":"14","key":"12_CR270","doi-asserted-by":"publisher","first-page":"R546","DOI":"10.1016\/j.cub.2004.07.007","volume":"14","author":"CL Peterson","year":"2004","unstructured":"Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14(14):R546\u2013R551","journal-title":"Curr Biol"},{"key":"12_CR271","doi-asserted-by":"publisher","first-page":"1245832","DOI":"10.3389\/freae.2023.1245832","volume":"1","author":"HQH Pham","year":"2023","unstructured":"Pham HQH, Tao X, Yang Y (2023) Protein arginine methylation in transcription and epigenetic regulation. Frontiers in Epigenetics and Epigenomics 1:1245832","journal-title":"Frontiers in Epigenetics and Epigenomics"},{"issue":"3","key":"12_CR272","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3324\/haematol.2011.051532","volume":"97","author":"M Pratcorona","year":"2012","unstructured":"Pratcorona M, Abbas S, Sanders MA, Koenders JE, Kavelaars FG, Erpelinck-Verschueren CA et al (2012) Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value. Haematologica 97(3):388","journal-title":"Haematologica"},{"issue":"3","key":"12_CR273","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1101\/gr.277089.122","volume":"33","author":"S Pundhir","year":"2023","unstructured":"Pundhir S, Su J, Tapia M, Hansen AM, Haile JS, Hansen K, Porse BT (2023) The impact of SWI\/SNF and NuRD inactivation on gene expression is tightly coupled with levels of RNA polymerase II occupancy at promoters. Genome Res 33(3):332\u2013345","journal-title":"Genome Res"},{"issue":"8","key":"12_CR274","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/cr.2015.72","volume":"25","author":"W Qin","year":"2015","unstructured":"Qin W, Wolf P, Liu N, Link S, Smets M, Mastra FL et al (2015) DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination. Cell Res 25(8):911\u2013929","journal-title":"Cell Res"},{"issue":"5","key":"12_CR275","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/ajh.27645","volume":"100","author":"S Qu","year":"2025","unstructured":"Qu S, Liu N, Sun Q, Wang H, Jia Y, Qin T et al (2025) The Molecular Features of Chronic Eosinophilic Leukemia, Not Otherwise Specified. Am J Hematol 100(5):928\u2013932","journal-title":"Am J Hematol"},{"issue":"9","key":"12_CR276","first-page":"805","volume":"2","author":"PJ Rauch","year":"2023","unstructured":"Rauch PJ, Gopakumar J, Silver AJ, Nachun D, Ahmad H, McConkey M et al (2023) Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes. Na Cardiovasc Res 2(9):805\u2013818","journal-title":"Nature Cardiovascular Research"},{"issue":"6","key":"12_CR277","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.3390\/ijms22062964","volume":"22","author":"E Reszka","year":"2021","unstructured":"Reszka E, Jab\u0142o\u0144ska E, Wieczorek E, Valent P, Arock M, Nilsson G et al (2021) Epigenetic changes in neoplastic mast cells and potential impact in mastocytosis. Int J Mol Sci 22(6):2964","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12_CR278","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/emboj.2011.431","volume":"31","author":"N Reynolds","year":"2012","unstructured":"Reynolds N, Salmon-Divon M, Dvinge H, Hynes-Allen A, Balasooriya G, Leaford D et al (2012) NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J 31(3):593\u2013605","journal-title":"EMBO J"},{"issue":"11","key":"12_CR279","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/nar\/27.11.2291","volume":"27","author":"KD Robertson","year":"1999","unstructured":"Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27(11):2291\u20132298","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"12_CR280","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1083\/jcb.146.5.905","volume":"146","author":"EP Rogakou","year":"1999","unstructured":"Rogakou EP, Boon C, Redon C, Bonner WM (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146(5):905\u2013916","journal-title":"J Cell Biol"},{"issue":"10","key":"12_CR281","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4161\/epi.21975","volume":"7","author":"D Rossetto","year":"2012","unstructured":"Rossetto D, Avvakumov N, C\u00f4t\u00e9 J (2012) Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7(10):1098\u20131108","journal-title":"Epigenetics"},{"issue":"8","key":"12_CR282","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41417-022-00441-w","volume":"29","author":"B Roux","year":"2022","unstructured":"Roux B, Picou F, Debeissat C, Koubi M, Gallay N, Hirsch P et al (2022) Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia. Cancer Gene Ther 29(8):1263\u20131275","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"12_CR283","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJD Ruijter","year":"2003","unstructured":"Ruijter AJD, Gennip AHV, Caron HN, Kemp S, Kuilenburg ABV (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370(3):737\u2013749","journal-title":"Biochem J"},{"issue":"31","key":"12_CR284","doi-asserted-by":"publisher","first-page":"49574","DOI":"10.18632\/oncotarget.10411","volume":"7","author":"P Rybak","year":"2016","unstructured":"Rybak P, Hoang A, Bujnowicz L, Bernas T, Berniak K, Zar\u0119bski M et al (2016) Low level phosphorylation of histone H2AX on serine 139 (\u03b3H2AX) is not associated with DNA double-strand breaks. Oncotarget 7(31):49574","journal-title":"Oncotarget"},{"issue":"2","key":"12_CR285","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molcel.2015.02.029","volume":"58","author":"BR Sabari","year":"2015","unstructured":"Sabari BR, Tang Z, Huang H, Yong-Gonzalez V, Molina H, Kong HE et al (2015) Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation. Mol Cell 58(2):203\u2013215","journal-title":"Mol Cell"},{"key":"12_CR286","doi-asserted-by":"crossref","unstructured":"Sato N, Goyama S & Kitamura T (2025) ASXL1 mutation-related clonal hematopoiesis and age-related diseases: clinical evidence and molecular insights. Int J Hematol 1-14.","DOI":"10.1007\/s12185-025-04038-5"},{"issue":"5","key":"12_CR287","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1073\/pnas.0510310103","volume":"103","author":"S Saxonov","year":"2006","unstructured":"Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proceedings of the National Academy of Sciences 103(5):1412\u20131417","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"12_CR288","doi-asserted-by":"publisher","first-page":"1652373","DOI":"10.3389\/fphar.2025.1652373","volume":"16","author":"L Schlemminger","year":"2025","unstructured":"Schlemminger L, Nagel I, Vater I, Cascorbi I, Kaehler M (2025) The role of the lysine histone methylase KMT2D in chronic myeloid leukemia. Front Pharmacol 16:1652373","journal-title":"Front Pharmacol"},{"issue":"4","key":"12_CR289","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s13311-013-0204-7","volume":"10","author":"A Schneider","year":"2013","unstructured":"Schneider A, Chatterjee S, Bousiges O, Selvi BR, Swaminathan A, Cassel R et al (2013) Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics 10(4):568\u2013588","journal-title":"Neurotherapeutics"},{"issue":"1","key":"12_CR290","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/1078-0432.CCR-20-3184","volume":"27","author":"M Sch\u00f6nung","year":"2021","unstructured":"Sch\u00f6nung M, Meyer J, N\u00f6llke P, Olshen AB, Hartmann M, Murakami N et al (2021) International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia. Clin Cancer Res 27(1):158\u2013168","journal-title":"Clin Cancer Res"},{"key":"12_CR291","doi-asserted-by":"crossref","unstructured":"Schrezenmeier J, Huntly BJP (2025, June) Epigenetic Dysregulation in Acute Myeloid Leukemia. In Seminars in Hematology. WB Saunders.","DOI":"10.1053\/j.seminhematol.2025.06.003"},{"issue":"7534","key":"12_CR292","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature14192","volume":"517","author":"D Sch\u00fcbeler","year":"2015","unstructured":"Sch\u00fcbeler D (2015) Function and information content of DNA methylation. Nature 517(7534):321\u2013326","journal-title":"Nature"},{"key":"12_CR293","doi-asserted-by":"publisher","first-page":"104131","DOI":"10.1016\/j.exphem.2023.11.005","volume":"130","author":"LS Schwartz","year":"2024","unstructured":"Schwartz LS, Young KA, Stearns TM, Boyer N, Mujica KD, Trowbridge JJ (2024) Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells. Exp Hematol 130:104131","journal-title":"Exp Hematol"},{"issue":"11","key":"12_CR294","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-16-0263","volume":"6","author":"MT Scott","year":"2016","unstructured":"Scott MT, Korfi K, Saffrey P, Hopcroft LE, Kinstrie R, Pellicano F et al (2016) Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition. Cancer Discovery 6(11):1248\u20131257","journal-title":"Cancer Discovery"},{"issue":"07","key":"12_CR295","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1055\/a-2239-9265","volume":"124","author":"A Segura-D\u00edaz","year":"2024","unstructured":"Segura-D\u00edaz A, Stuckey R, Florido Y, Sobas M, \u00c1lvarez-Larr\u00e1n A, Ferrer-Mar\u00edn F et al (2024) DNMT3A\/TET2\/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational study. Thromb Haemost 124(07):669\u2013675","journal-title":"Thromb Haemost"},{"issue":"10","key":"12_CR296","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1074\/jbc.M109.063933","volume":"285","author":"BR Selvi","year":"2010","unstructured":"Selvi BR, Batta K, Kishore AH, Mantelingu K, Varier RA, Balasubramanyam K et al (2010) Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. J Biol Chem 285(10):7143\u20137152","journal-title":"J Biol Chem"},{"issue":"4","key":"12_CR297","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harbor Perspect Biol 6(4):a018713","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"1","key":"12_CR298","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","volume":"76","author":"MD Shahbazian","year":"2007","unstructured":"Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76(1):75\u2013100","journal-title":"Annu Rev Biochem"},{"key":"12_CR299","doi-asserted-by":"crossref","unstructured":"Shammas T, Peiris MN, Meyer AN & Donoghue DJ (2025) BCR-ABL: The Molecular Mastermind behind Chronic Myeloid Leukemia. Cytokine & Growth Factor Reviews.","DOI":"10.1016\/j.cytogfr.2025.05.001"},{"issue":"1","key":"12_CR300","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13465","volume":"7","author":"WH Shang","year":"2016","unstructured":"Shang WH, Hori T, Westhorpe FG, Godek KM, Toyoda A, Misu S et al (2016) Acetylation of histone H4 lysine 5 and 12 is required for CENP-A deposition into centromeres. Nat Commun 7(1):13465","journal-title":"Nat Commun"},{"issue":"10","key":"12_CR301","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1101\/gr.112680.110","volume":"21","author":"AJ Sharp","year":"2011","unstructured":"Sharp AJ, Stathaki E, Migliavacca E, Brahmachary M, Montgomery SB, Dupre Y, Antonarakis SE (2011) DNA methylation profiles of human active and inactive X chromosomes. Genome Res 21(10):1592\u20131600","journal-title":"Genome Res"},{"issue":"12","key":"12_CR302","first-page":"1586","volume":"129","author":"A Shastri","year":"2017","unstructured":"Shastri A, Will B, Steidl U, Verma A (2017) Stem and progenitor cell alterations in myelodysplastic syndromes. Blood, Am Soc Hematol 129(12):1586\u20131594","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"4","key":"12_CR303","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2009.23.4781","volume":"28","author":"L Shen","year":"2010","unstructured":"Shen L, Kantarjian H, Guo Y, Lin E, Shan J, Huang X et al (2010) DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol 28(4):605\u2013613","journal-title":"J Clin Oncol"},{"key":"12_CR304","doi-asserted-by":"publisher","first-page":"1513654","DOI":"10.3389\/fonc.2024.1513654","volume":"14:","author":"ZA Sherif","year":"2025","unstructured":"Sherif ZA, Ogunwobi OO, Ressom HW (2025) Mechanisms and technologies in cancer epigenetics. Front Oncol 14::1513654","journal-title":"Front Oncol"},{"issue":"5","key":"12_CR305","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-5-217","volume":"7","author":"WJ Shia","year":"2006","unstructured":"Shia WJ, Pattenden SG, Workman JL (2006) Histone H4 lysine 16 acetylation breaks the genome\u2019s silence. Genome Biol 7(5):217","journal-title":"Genome Biol"},{"issue":"23","key":"12_CR306","doi-asserted-by":"publisher","first-page":"13225","DOI":"10.1073\/pnas.1735528100","volume":"100","author":"Y Shiio","year":"2003","unstructured":"Shiio Y, Eisenman RN (2003) Histone sumoylation is associated with transcriptional repression. Proceedings of the National Academy of Sciences 100(23):13225\u201313230","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"12_CR307","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.leukres.2017.10.015","volume":"63","author":"M Shirahata-Adachi","year":"2017","unstructured":"Shirahata-Adachi M, Iriyama C, Tomita A, Suzuki Y, Shimada K, Kiyoi H (2017) Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome. Leuk Res 63:90\u201397","journal-title":"Leuk Res"},{"issue":"1","key":"12_CR308","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25051-2","volume":"12","author":"M Shoaib","year":"2021","unstructured":"Shoaib M, Chen Q, Shi X, Nair N, Prasanna C, Yang R et al (2021) Histone H4 lysine 20 mono-methylation directly facilitates chromatin openness and promotes transcription of housekeeping genes. Nat Commun 12(1):4800","journal-title":"Nat Commun"},{"issue":"18","key":"12_CR309","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1182\/bloodadvances.2021004237","volume":"5","author":"W Shomali","year":"2021","unstructured":"Shomali W, Damnernsawad A, Theparee T, Sampson D, Morrow Q, Yang F et al (2021) A novel activating JAK1 mutation in chronic eosinophilic leukemia. Blood Adv 5(18):3581\u20133586","journal-title":"Blood Adv"},{"issue":"1","key":"12_CR310","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43003-w","volume":"15","author":"M Shumliakivska","year":"2024","unstructured":"Shumliakivska M, Lux\u00e1n G, Hemmerling I, Scheller M, Li X, M\u00fcller-Tidow C et al (2024) DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts. Nat Commun 15(1):606","journal-title":"Nat Commun"},{"issue":"18","key":"12_CR311","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1158\/0008-5472.CAN-14-3702","volume":"75","author":"L Sim\u00f3-Riudalbas","year":"2015","unstructured":"Sim\u00f3-Riudalbas L, P\u00e9rez-Salvia M, Setien F, Villanueva A, Moutinho C, Mart\u00ednez-Card\u00fas A et al (2015) KAT6B is a tumor suppressor histone H3 lysine 23 acetyltransferase undergoing genomic loss in small cell lung cancer. Cancer Res 75(18):3936\u20133945","journal-title":"Cancer Res"},{"issue":"21","key":"12_CR312","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.3390\/cancers15215204","volume":"15","author":"R Sinha","year":"2023","unstructured":"Sinha R, Dvorak M, Ganesan A, Kalesinskas L, Niemeyer CM, Flotho C et al (2023) Epigenetic profiling of PTPN11 mutant JMML hematopoietic stem and progenitor cells reveals an aberrant histone landscape. Cancers 15(21):5204","journal-title":"Cancers"},{"issue":"6","key":"12_CR313","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1042\/EBC20190037","volume":"63","author":"K Skvortsova","year":"2019","unstructured":"Skvortsova K, Stirzaker C, Taberlay P (2019) The DNA methylation landscape in cancer. Essays Biochem 63(6):797\u2013811","journal-title":"Essays Biochem"},{"issue":"5","key":"12_CR314","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41556-019-0314-5","volume":"21","author":"MA Smith","year":"2019","unstructured":"Smith MA, Choudhary GS, Pellagatti A, Choi K, Bolanos LC, Bhagat TD et al (2019) U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies. Nature Cell Biol 21(5):640\u2013650","journal-title":"Nature Cell Biol"},{"issue":"3","key":"12_CR315","doi-asserted-by":"publisher","first-page":"985","DOI":"10.21873\/invivo.13172","volume":"37","author":"J Song","year":"2023","unstructured":"Song J, Moscinski L, Yang E, Shao H, Hussaini M, Zhang H (2023) Co-mutation of ASXL1 and SF3B1 predicts poorer overall survival than isolated ASXL1 or SF3B1 mutations. In Vivo 37(3):985\u2013993","journal-title":"In Vivo"},{"issue":"2","key":"12_CR316","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4274\/tjh.2016.0401","volume":"34","author":"N Soyer","year":"2017","unstructured":"Soyer N, Kaymaz BT, \u00d6zkan MC, Aktan \u00c7, K\u00fc\u00e7\u00fckaslan A\u015e, \u015eahin F et al (2017) TET2, ASXL1, IDH1, and IDH2 Single nucleotide polymorphisms in Turkish patients with chronic myeloproliferative neoplasms. Turk J Haematol 34(2):174","journal-title":"Turk J Haematol"},{"issue":"12","key":"12_CR317","first-page":"1462","volume":"126","author":"J Sperlazza","year":"2015","unstructured":"Sperlazza J, Rahmani M, Beckta J, Aust M, Hawkins E, Wang SZ et al (2015) Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation. Blood, Am Soc Hematol 126(12):1462\u20131472","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"12_CR318","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2016.112","volume":"17","author":"AS Sperling","year":"2017","unstructured":"Sperling AS, Gibson CJ, Ebert BL (2017) The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer 17(1):5\u201319","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"12_CR319","first-page":"1529","volume":"31","author":"C Stapnes","year":"2007","unstructured":"Stapnes C, Ryningen A, Hatfield K, \u00d8yan AM, Eide GE, Corbascio M et al (2007) Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors. Int J Oncol 31(6):1529\u20131538","journal-title":"Int J Oncol"},{"issue":"5","key":"12_CR320","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.3324\/haematol.2019.222323","volume":"105","author":"S Stasik","year":"2020","unstructured":"Stasik S, Middeke JM, Kramer M, R\u00f6llig C, Kr\u00e4mer A, Scholl S et al (2020) EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia. Haematologica 105(5):e228","journal-title":"Haematologica"},{"issue":"1","key":"12_CR321","first-page":"264","volume":"2018","author":"DP Steensma","year":"2018","unstructured":"Steensma DP (2018) Clinical consequences of clonal hematopoiesis of indeterminate potential. Hematology 2014, the American Society of Hematology Education Program Book 2018(1):264\u2013269","journal-title":"Hematology 2014, the American Society of Hematology Education Program Book"},{"issue":"7","key":"12_CR322","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/leu.2011.77","volume":"25","author":"F Stegelmann","year":"2011","unstructured":"Stegelmann F, Bullinger L, Schlenk RF, Paschka P, Griesshammer M, Blersch C et al (2011) DNMT3A mutations in myeloproliferative neoplasms. Leukemia 25(7):1217\u20131219","journal-title":"Leukemia"},{"issue":"45","key":"12_CR323","doi-asserted-by":"publisher","first-page":"39457","DOI":"10.1074\/jbc.M111.243006","volume":"286","author":"LA Steiner","year":"2011","unstructured":"Steiner LA, Schulz VP, Maksimova Y, Wong C, Gallagher PG (2011) Patterns of histone H3 lysine 27 monomethylation and erythroid cell type-specific gene expression. J Biol Chem 286(45):39457\u201339465","journal-title":"J Biol Chem"},{"issue":"1","key":"12_CR324","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02178-9","volume":"8","author":"E Stieglitz","year":"2017","unstructured":"Stieglitz E, Mazor T, Olshen AB, Geng H, Gelston LC, Akutagawa J et al (2017) Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia. Nat Commun 8(1):2127","journal-title":"Nat Commun"},{"issue":"6765","key":"12_CR325","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41\u201345","journal-title":"Nature"},{"issue":"26","key":"12_CR326","doi-asserted-by":"publisher","first-page":"27816","DOI":"10.1074\/jbc.M400181200","volume":"279","author":"I Suetake","year":"2004","unstructured":"Suetake I, Shinozaki F, Miyagawa J, Takeshima H, Tajima S (2004) DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J Biol Chem 279(26):27816\u201327823","journal-title":"J Biol Chem"},{"issue":"4","key":"12_CR327","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ajh.26481","volume":"97","author":"N Szuber","year":"2022","unstructured":"Szuber N, Elliott M, Tefferi A (2022) Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management. Am J Hematol 97(4):491\u2013505","journal-title":"Am J Hematol"},{"issue":"7","key":"12_CR328","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/ajh.27321","volume":"99","author":"N Szuber","year":"2024","unstructured":"Szuber N, Orazi A, Tefferi A (2024) Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management. Am J Hematol 99(7):1360\u20131387","journal-title":"Am J Hematol"},{"key":"12_CR329","doi-asserted-by":"publisher","first-page":"1419323","DOI":"10.3389\/frhem.2024.1419323","volume":"3","author":"CC Taborda","year":"2024","unstructured":"Taborda CC, Zeidan AM, Mendez LM (2024) Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets. Front Hematol 3:1419323","journal-title":"Frontiers in Hematology"},{"issue":"5929","key":"12_CR330","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929):930\u2013935","journal-title":"Science"},{"issue":"6","key":"12_CR331","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1073\/pnas.052410099","volume":"99","author":"D Takai","year":"2002","unstructured":"Takai D, Jones PA (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci 99(6):3740\u20133745","journal-title":"Proceedings of the national academy of sciences"},{"issue":"5","key":"12_CR332","first-page":"1107","volume":"120","author":"S Tanaka","year":"2012","unstructured":"Tanaka S, Miyagi S, Sashida G, Chiba T, Yuan J, Mochizuki-Kashio M et al (2012) Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood, Am Soc Hematol 120(5):1107\u20131117","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"22","key":"12_CR333","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1182\/blood.V128.22.3158.3158","volume":"128","author":"TN Tanaka","year":"2016","unstructured":"Tanaka TN, Reilly B, Diep D, Zhang K, Bejar R (2016) Methylation Profiling Among Patients with TET2 Mutations in Myelodysplastic Syndromes Is Associated with Overall Survival. Blood 128(22):3158","journal-title":"Blood"},{"issue":"4","key":"12_CR334","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2184.2006.00387.x","volume":"39","author":"T Tanaka","year":"2006","unstructured":"Tanaka T, Kurose A, Huang X, Traganos F, Dai W, Darzynkiewicz Z (2006) Extent of constitutive histone H2AX phosphorylation on Ser-139 varies in cells with different TP53 status. Cell Proliferation 39(4):313\u2013323","journal-title":"Cell Proliferation"},{"issue":"4","key":"12_CR335","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/leu.2015.308","volume":"30","author":"SS Tarighat","year":"2016","unstructured":"Tarighat SS, Santhanam R, Frankhouser D, Radomska HS, Lai H, Anghelina M, Marcucci G (2016) The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia 30(4):789\u2013799","journal-title":"Leukemia"},{"issue":"1","key":"12_CR336","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","volume":"1","author":"A Tefferi","year":"2015","unstructured":"Tefferi A, Pardanani A (2015) Myeloproliferative neoplasms: a contemporary review. JAMA oncology 1(1):97\u2013105","journal-title":"JAMA oncology"},{"issue":"7","key":"12_CR337","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/leu.2010.113","volume":"24","author":"A Tefferi","year":"2010","unstructured":"Tefferi A, Lasho TL, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D et al (2010) IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic-or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis. Leukemia 24(7):1302\u20131309","journal-title":"Leukemia"},{"issue":"11","key":"12_CR338","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz P, Kouzarides T (2014) Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol 15(11):703\u2013708","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"32","key":"12_CR339","doi-asserted-by":"publisher","first-page":"eadg9832","DOI":"10.1126\/sciadv.adg9832","volume":"9","author":"JF Thomas","year":"2023","unstructured":"Thomas JF, Valencia-S\u00e1nchez MI, Tamburri S, Gloor SL, Rustichelli S, God\u00ednez-L\u00f3pez V et al (2023) Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1\/ASXL1. Sci Adv 9(32):eadg9832","journal-title":"Sci Adv"},{"key":"12_CR340","doi-asserted-by":"publisher","first-page":"891961","DOI":"10.3389\/fonc.2022.891961","volume":"12","author":"TP Thomopoulos","year":"2022","unstructured":"Thomopoulos TP, Symeonidis A, Kourakli A, Papageorgiou SG, Pappa V (2022) Chronic neutrophilic leukemia: a comprehensive review of clinical characteristics, genetic landscape and management. Front Oncol 12:891961","journal-title":"Front Oncol"},{"issue":"18","key":"12_CR341","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1242\/dev.037127","volume":"136","author":"F Tie","year":"2009","unstructured":"Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A et al (2009) CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development 136(18):3131\u20133141","journal-title":"Development"},{"issue":"4","key":"12_CR342","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1038\/bcj.2017.36","volume":"7","author":"E Togasaki","year":"2017","unstructured":"Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M et al (2017) Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia. Blood Cancer J 7(4):e559\u2013e559","journal-title":"Blood Cancer J"},{"issue":"14","key":"12_CR343","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1074\/jbc.TM118.000831","volume":"294","author":"KA Tran","year":"2019","unstructured":"Tran KA, Dillingham CM, Sridharan R (2019) The role of \u03b1-ketoglutarate\u2013dependent proteins in pluripotency acquisition and maintenance. J Biol Chem 294(14):5408\u20135419","journal-title":"J Biol Chem"},{"key":"12_CR344","doi-asserted-by":"crossref","unstructured":"Tremblay D, Hasserjian RP & Rampal RK (2025) Myelodysplastic syndrome\/myeloproliferative neoplasm overlap syndromes: a practical guide to diagnosis and management. Leukemia 1-14.","DOI":"10.1038\/s41375-025-02620-8"},{"issue":"2","key":"12_CR345","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.hoc.2020.12.001","volume":"35","author":"D Tremblay","year":"2021","unstructured":"Tremblay D, Yacoub A, Hoffman R (2021) Overview of MPNs: History, Pathogenesis, Diagnostic Criteria, and Complications. Hematol Oncol Clin North Am 35(2):159","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"12_CR346","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26093-2","volume":"12","author":"M Tulstrup","year":"2021","unstructured":"Tulstrup M, Soerensen M, Hansen JW, Gillberg L, Needhamsen M, Kaastrup K et al (2021) TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis. Nat Commun 12(1):6061","journal-title":"Nat Commun"},{"issue":"4","key":"12_CR347","first-page":"1403","volume":"90","author":"T Uchida","year":"1997","unstructured":"Uchida T, Kinoshita T, Nagai H, Nakahara Y, Saito H, Hotta T, Murate T (1997) Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. Blood, The Journal of the American Society of Hematology 90(4):1403\u20131409","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"3","key":"12_CR348","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3346\/jkms.2009.24.3.493","volume":"24","author":"KO Uhm","year":"2009","unstructured":"Uhm KO, Lee ES, Lee YM, Park JS, Kim SJ, Kim BS et al (2009) Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia. J Korean Med Sci 24(3):493\u2013497","journal-title":"J Korean Med Sci"},{"key":"12_CR349","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.pharmthera.2018.11.001","volume":"195","author":"A Unnikrishnan","year":"2019","unstructured":"Unnikrishnan A, Freeman WM, Jackson J, Wren JD, Porter H, Richardson A (2019) The role of DNA methylation in epigenetics of aging. Pharmacol Ther 195:172\u2013185","journal-title":"Pharmacol Ther"},{"issue":"10","key":"12_CR350","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3324\/haematol.2016.146563","volume":"101","author":"C Ustun","year":"2016","unstructured":"Ustun C, Arock M, Kluin-Nelemans HC, Reiter A, Sperr WR, George T et al (2016) Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice. Haematologica 101(10):1133\u20131143","journal-title":"Haematologica"},{"issue":"1","key":"12_CR351","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01011-x","volume":"13","author":"AD van Dijk","year":"2021","unstructured":"van Dijk AD, Hoff FW, Qiu YH, Chandra J, Jabbour E, de Bont ESJM et al (2021) Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia. Clin Epigenetics 13(1):21","journal-title":"Clin Epigenetics"},{"issue":"3","key":"12_CR352","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1074\/mcp.R115.054742","volume":"15","author":"R van Nuland","year":"2016","unstructured":"van Nuland R, Gozani O (2016) Histone H4 lysine 20 (H4K20) methylation, expanding the signaling potential of the proteome one methyl moiety at a time. Mol Cell Proteomics 15(3):755\u2013764","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"12_CR353","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","volume":"19","author":"E Verdin","year":"2003","unstructured":"Verdin E, Dequiedt F, Kasler HG (2003) Class II histone deacetylases: versatile regulators. TIG 19(5):286\u2013293","journal-title":"TIG"},{"key":"12_CR354","doi-asserted-by":"publisher","first-page":"S444","DOI":"10.1016\/j.htct.2023.09.829","volume":"45","author":"MA Viana","year":"2023","unstructured":"Viana MA, Oliveira RTG, Costa MB, Monte CS, Borges DP, Ribeiro FJAB et al (2023) HYPERMETHYLATION OF DNA REPAIR GENES IS LINKED TO PROGNOSIS OF MYELODYSPLASTIC NEOPLASM. Hematology, Transfusion and Cell Therapy 45:S444","journal-title":"Hematology, Transfusion and Cell Therapy"},{"issue":"6","key":"12_CR355","first-page":"375","volume":"20","author":"N Vobugari","year":"2022","unstructured":"Vobugari N, Heuston C, Lai C (2022) Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies. Clin Adv Hematol Oncol 20(6):375\u2013383","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"12_CR356","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2006.07.009","volume":"89","author":"P V\u00f6lkel","year":"2007","unstructured":"V\u00f6lkel P, Angrand PO (2007) The control of histone lysine methylation in epigenetic regulation. Biochimie 89(1):1\u201320","journal-title":"Biochimie"},{"key":"12_CR357","doi-asserted-by":"publisher","first-page":"1273046","DOI":"10.3389\/fmolb.2023.1273046","volume":"10","author":"L Wallace","year":"2023","unstructured":"Wallace L, Obeng EA (2023) Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis. Front Mol Biosci 10:1273046","journal-title":"Front Mol Biosci"},{"issue":"7","key":"12_CR358","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/leu.2011.44","volume":"25","author":"MJ Walter","year":"2011","unstructured":"Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al (2011) Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25(7):1153\u20131158","journal-title":"Leukemia"},{"issue":"6001","key":"12_CR359","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.1189435","volume":"330","author":"F Wang","year":"2010","unstructured":"Wang F, Dai J, Daum JR, Niedzialkowska E, Banerjee B, Stukenberg PT et al (2010) Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science 330(6001):231\u2013235","journal-title":"Science"},{"issue":"14","key":"12_CR360","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.cell.2024.05.003","volume":"187","author":"H Wang","year":"2024","unstructured":"Wang H, Divaris K, Pan B, Li X, Lim JH, Saha G et al (2024) Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell 187(14):3690\u20133711","journal-title":"Cell"},{"issue":"8","key":"12_CR361","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/modpathol.2016.75","volume":"29","author":"SA Wang","year":"2016","unstructured":"Wang SA, Tam W, Tsai AG, Arber DA, Hasserjian RP, Geyer JT et al (2016) Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol 29(8):854\u2013864","journal-title":"Mod Pathol"},{"issue":"2","key":"12_CR362","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00277-020-04387-7","volume":"100","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liu W, Wang M, Li Y, Wang X, Yang E et al (2021) Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis. Ann Hematol 100(2):465\u2013479","journal-title":"Ann Hematol"},{"issue":"2","key":"12_CR363","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/epi.11.9","volume":"3","author":"Y Wei","year":"2011","unstructured":"Wei Y, Ga\u00f1\u00e1n-G\u00f3mez I, Salazar-Dimicoli S, McCay SL, Garcia-Manero G (2011) Histone methylation in myelodysplastic syndromes. Epigenomics 3(2):193\u2013205","journal-title":"Epigenomics"},{"issue":"1","key":"12_CR364","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0092-8674(00)80718-7","volume":"97","author":"Y Wei","year":"1999","unstructured":"Wei Y, Yu L, Bowen J, Gorovsky MA, Allis CD (1999) Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 97(1):99\u2013109","journal-title":"Cell"},{"issue":"1","key":"12_CR365","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1365-2141.1997.d01-1991.x","volume":"96","author":"R Weide","year":"1997","unstructured":"Weide R, Rieder H, Mehraein Y, Wolf M, Kaiser U, Seifart U et al (1997) Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. Br J Haematol 96(1):117\u2013123","journal-title":"Br J Haematol"},{"issue":"1","key":"12_CR366","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00899-2","volume":"27","author":"DL Wu","year":"2022","unstructured":"Wu DL, Wang Y, Zhang TJ, Chu MQ, Xu ZJ, Yuan Q et al (2022) SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia. Eur J Med Res 27(1):259","journal-title":"Eur J Med Res"},{"issue":"12","key":"12_CR367","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC et al (2014) Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nature Med 20(12):1472\u20131478","journal-title":"Nature Med"},{"issue":"4","key":"12_CR368","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.molcel.2009.02.004","volume":"33","author":"W Xie","year":"2009","unstructured":"Xie W, Song C, Young NL, Sperling AS, Xu F, Sridharan R et al (2009) Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell 33(4):417\u2013427","journal-title":"Mol Cell"},{"issue":"7","key":"12_CR369","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1073\/pnas.1400150111","volume":"111","author":"J Xu","year":"2014","unstructured":"Xu J, Wang YY, Dai YJ, Zhang W, Zhang WN, Xiong SM et al (2014a) DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression\/DNA methylation in hematopoietic cells. Proceedings of the National Academy of Sciences 111(7):2620\u20132625","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9","key":"12_CR370","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1093\/nar\/gku236","volume":"42","author":"Q Xu","year":"2014","unstructured":"Xu Q, Yang C, Du Y, Chen Y, Liu H, Deng M et al (2014b) AMPK regulates histone H2B O-GlcNAcylation. Nucleic Acids Res 42(9):5594\u20135604","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"12_CR371","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47314-4","volume":"15","author":"K Yamaguchi","year":"2024","unstructured":"Yamaguchi K, Chen X, Rodgers B, Miura F, Bashtrykov P, Bonhomme F et al (2024) Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells. Nat Commun 15(1):2960","journal-title":"Nat Commun"},{"issue":"4","key":"12_CR372","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/epigenomes7040032","volume":"7","author":"B Yan","year":"2023","unstructured":"Yan B, Yuan Q, Guryanova OA (2023) Epigenetic Mechanisms in Hematologic Aging and Premalignant Conditions. Epigenomes 7(4):32","journal-title":"Epigenomes"},{"issue":"3","key":"12_CR373","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/2159-8290.CD-20-1459","volume":"12","author":"F Yan","year":"2022","unstructured":"Yan F, Li J, Milosevic J, Petroni R, Liu S, Shi Z et al (2022) KAT6A and ENL form an epigenetic transcriptional control module to drive critical leukemogenic gene-expression programs. Cancer Discov 12(3):792\u2013811","journal-title":"Cancer Discovery"},{"issue":"4","key":"12_CR374","doi-asserted-by":"publisher","first-page":"eaax0021","DOI":"10.1126\/sciadv.aax0021","volume":"6","author":"K Yan","year":"2020","unstructured":"Yan K, Rousseau J, Machol K, Cross LA, Agre KE, Gibson CF et al (2020) Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer. Sci Adv 6(4):eaax0021","journal-title":"Sci Adv"},{"issue":"1","key":"12_CR375","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molcel.2009.08.019","volume":"36","author":"Q Yan","year":"2009","unstructured":"Yan Q, Dutt S, Xu R, Graves K, Juszczynski P, Manis JP, Shipp MA (2009) BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response. Mol Cell 36(1):110\u2013120","journal-title":"Mol Cell"},{"issue":"1","key":"12_CR376","doi-asserted-by":"publisher","first-page":"e6871","DOI":"10.1002\/cam4.6871","volume":"13","author":"L Yang","year":"2024","unstructured":"Yang L, Wei X, Gong Y (2024) Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Cancer Med 13(1):e6871","journal-title":"Cancer Med"},{"issue":"18","key":"12_CR377","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.3390\/ijms20184576","volume":"20","author":"X Yang","year":"2019","unstructured":"Yang X, Wong MPM, Ng RK (2019) Aberrant DNA methylation in acute myeloid leukemia and its clinical implications. Int J Mol Sci 20(18):4576","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12_CR378","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jncc.2022.09.002","volume":"2","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang M, Wang Y (2022) The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy. Journal of the National Cancer Center 2(4):277\u2013290","journal-title":"Journal of the National Cancer Center"},{"issue":"12","key":"12_CR379","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1021\/bi101885m","volume":"50","author":"KL Yap","year":"2011","unstructured":"Yap KL, Zhou MM (2011) Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription. Biochemistry 50(12):1966\u20131980","journal-title":"Biochemistry"},{"issue":"1","key":"12_CR380","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molcel.2005.02.031","volume":"18","author":"J Ye","year":"2005","unstructured":"Ye J, Ai X, Eugeni EE, Zhang L, Carpenter LR, Jelinek MA et al (2005) Histone H4 lysine 91 acetylation: A core domain modificationassociated with chromatin assembly. Mol Cell 18(1):123\u2013130","journal-title":"Mol Cell"},{"key":"12_CR381","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3389\/fphar.2019.01393","volume":"10","author":"C Yu","year":"2019","unstructured":"Yu C, Zhuang S (2019) Histone methyltransferases as therapeutic targets for kidney diseases. Front Pharmacol 10:1393","journal-title":"Front Pharmacol"},{"issue":"1","key":"12_CR382","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Zhao H, Wang R, Chen Y, Ouyang X, Li W et al (2024) Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov 10(1):28","journal-title":"Cell Death Discov"},{"issue":"1","key":"12_CR383","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00786-y","volume":"13","author":"S Zehtabcheh","year":"2025","unstructured":"Zehtabcheh S, Soleimani Samarkhazan H, Asadi M, Zabihi M, Parkhideh S, Mohammadi MH (2025) Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies. Biomark Res 13(1):73","journal-title":"Biomark Res"},{"issue":"25","key":"12_CR384","doi-asserted-by":"publisher","first-page":"e2322689121","DOI":"10.1073\/pnas.2322689121","volume":"121","author":"S Zentout","year":"2024","unstructured":"Zentout S, Imburchia V, Chapuis C, Duma L, Sch\u00fctzenhofer K, Prokhorova E et al (2024) Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions. Proc Nat Acad Sci 121(25):e2322689121","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"12_CR385","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","volume":"17","author":"B Zhang","year":"2010","unstructured":"Zhang B, Strauss AC, Chu S, Li M, Ho Y, Shiang KD et al (2010) Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 17(5):427\u2013442","journal-title":"Cancer Cell"},{"key":"12_CR386","doi-asserted-by":"publisher","first-page":"621578","DOI":"10.3389\/fcell.2020.621578","volume":"8","author":"LQ Zhang","year":"2021","unstructured":"Zhang LQ, Fan GL, Liu JJ, Liu L, Li QZ, Lin H (2021) Identification of key histone modifications and their regulatory regions on gene expression level changes in chronic myelogenous leukemia. Front Cell Dev Biol 8:621578","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"12_CR387","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.18632\/aging.103520","volume":"12","author":"TJ Zhang","year":"2020","unstructured":"Zhang TJ, Zhang LC, Xu ZJ, Zhou JD (2020) Expression and prognosis analysis of DNMT family in acute myeloid leukemia. Aging 12(14):14677","journal-title":"Aging"},{"issue":"11","key":"12_CR388","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.15252\/embr.201540945","volume":"16","author":"T Zhang","year":"2015","unstructured":"Zhang T, Cooper S, Brockdorff N (2015) The interplay of histone modifications\u2013writers that read. EMBO Rep 16(11):1467\u20131481","journal-title":"EMBO Rep"},{"issue":"21","key":"12_CR389","doi-asserted-by":"publisher","first-page":"21866","DOI":"10.1074\/jbc.M400099200","volume":"279","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Griffin K, Mondal N, Parvin JD (2004) Phosphorylation of histone H2A inhibits transcription on chromatin templates. J Biol Chem 279(21):21866\u201321872","journal-title":"J Biol Chem"},{"issue":"1","key":"12_CR390","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41392-023-01537-x","volume":"8","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang Y, Wang C, Wang X (2023) TET (Ten-eleven translocation) family proteins: structure, biological functions and applications. Signal Transduct Target Ther 8(1):297","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12_CR391","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","volume":"8","author":"A Zhao","year":"2023","unstructured":"Zhao A, Zhou H, Yang J, Li M, Niu T (2023) Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduct Target Ther 8(1):71","journal-title":"Signal Transduct Target Ther"},{"key":"12_CR392","doi-asserted-by":"crossref","unstructured":"Zhao Y, Xu F, Guo J, Zhao S, Chang C & Li X (2016) Dysregulation of ANKRD11 Influenced Hematopoisis By Histone Acetylation-Mediated Gene Expression in Myelodysplastic Syndrome.","DOI":"10.1182\/blood.V128.22.4292.4292"},{"key":"12_CR393","doi-asserted-by":"publisher","first-page":"e17667","DOI":"10.7554\/eLife.17667","volume":"5","author":"CY Zhen","year":"2016","unstructured":"Zhen CY, Tatavosian R, Huynh TN, Duc HN, Das R, Kokotovic M et al (2016) Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin. eLife 5:e17667","journal-title":"eLife"},{"issue":"1","key":"12_CR394","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17066-y","volume":"11","author":"Q Zheng","year":"2020","unstructured":"Zheng Q, Osunsade A, David Y (2020) Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation. Nat Commun 11(1):3241","journal-title":"Nat Commun"},{"issue":"34","key":"12_CR395","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1038\/sj.onc.1206507","volume":"22","author":"S Zhong","year":"2003","unstructured":"Zhong S, Goto H, Inagaki M, Dong Z (2003) Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. Oncogene 22(34):5291\u20135297","journal-title":"Oncogene"},{"issue":"16","key":"12_CR396","doi-asserted-by":"publisher","first-page":"12932","DOI":"10.1074\/jbc.M010931200","volume":"276","author":"S Zhong","year":"2001","unstructured":"Zhong S, Zhang Y, Jansen C, Goto H, Inagaki M, Dong Z (2001) MAP kinases mediate UVB-induced phosphorylation of histone H3 at serine 28. J Biol Chem 276(16):12932\u201312937","journal-title":"J Biol Chem"},{"key":"12_CR397","doi-asserted-by":"publisher","first-page":"897898","DOI":"10.3389\/fonc.2022.897898","volume":"12","author":"JD Zhou","year":"2022","unstructured":"Zhou JD, Xu ZJ, Jin Y, Zhang XL, Gu Y, Ma JC et al (2022) Whole-genome DNA methylation sequencing reveals epigenetic changes in myelodysplastic syndromes. Front Oncol 12:897898","journal-title":"Front Oncol"},{"issue":"11","key":"12_CR398","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41419-020-03213-2","volume":"11","author":"JD Zhou","year":"2020","unstructured":"Zhou JD, Zhang TJ, Xu ZJ, Deng ZQ, Gu YU, Ma JC et al (2020) Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes. Cell Death & Disease 11(11):997","journal-title":"Cell Death & Disease"},{"issue":"1","key":"12_CR399","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/nar\/gkaa1176","volume":"49","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Han Z, Halabelian L, Yang X, Ding J, Zhang N et al (2021) Identification of lysine isobutyrylation as a new histone modification mark. Nucleic Acids Res 49(1):177\u2013189","journal-title":"Nucleic Acids Res"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:02:42Z","timestamp":1783771362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":395,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}